From: Subject: Mergers and Acquisition Scenario Report Date: Fri, 4 May 2007 15:08:37 -0700 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_0046_01C78E5E.17466D70" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3028 This is a multi-part message in MIME format. ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://research.reveredata.com/rp/xa/reports/mna?co1=214902&co2=8745&fin=0%3DbuyerSharePrice%253D43.4500007629395%2526targetSharePrice%253D74.7600021362305%2526usePercentDeal%253Dtrue%2526dealStockPercent%253D1.0%2526dealCashPercent%253D0.0%2526dealDebtPercent%253D0.0%2526costOfCash%253D0.05%2526costOfDebt%253D0.06%2526intangiblesAcquired%253D0.0%2526rndWriteOffGoodwillPercent%253D0.0%2526yearsToAmortizeAcquiredIntangibles%253D7.0%2526estDealCost%253D0.0%2526synergy%253D0.0%2526usePercentSgaSynergy%253Dtrue%2526synergyPercentOfSga%253D0.0%261%3DbuyerSharePrice%253D43.4500007629395%2526targetSharePrice%253D82.23600234985355%2526usePercentDeal%253Dtrue%2526dealStockPercent%253D1.0%2526dealCashPercent%253D0.0%2526dealDebtPercent%253D0.0%2526costOfCash%253D0.05%2526costOfDebt%253D0.06%2526intangiblesAcquired%253D0.0%2526rndWriteOffGoodwillPercent%253D0.0%2526yearsToAmortizeAcquiredIntangibles%253D7.0%2526estDealCost%253D0.0%2526synergy%253D0.0%2526usePercentSgaSynergy%253Dtrue%2526synerg yPercentOfSga%253D0.0%262%3DbuyerSharePrice%253D43.4500007629395%2526targetSharePrice%253D89.7120025634766%2526usePercentDeal%253Dtrue%2526dealStockPercent%253D1.0%2526dealCashPercent%253D0.0%2526dealDebtPercent%253D0.0%2526costOfCash%253D0.05%2526costOfDebt%253D0.06%2526intangiblesAcquired%253D0.0%2526rndWriteOffGoodwillPercent%253D0.0%2526yearsToAmortizeAcquiredIntangibles%253D7.0%2526estDealCost%253D0.0%2526synergy%253D0.0%2526usePercentSgaSynergy%253Dtrue%2526synergyPercentOfSga%253D0.0%263%3DbuyerSharePrice%253D43.4500007629395%2526targetSharePrice%253D97.18800277709965%2526usePercentDeal%253Dtrue%2526dealStockPercent%253D1.0%2526dealCashPercent%253D0.0%2526dealDebtPercent%253D0.0%2526costOfCash%253D0.05%2526costOfDebt%253D0.06%2526intangiblesAcquired%253D0.0%2526rndWriteOffGoodwillPercent%253D0.0%2526yearsToAmortizeAcquiredIntangibles%253D7.0%2526estDealCost%253D0.0%2526synergy%253D0.0%2526usePercentSgaSynergy%253Dtrue%2526synergyPercentOfSga%253D0.0 Mergers and Acquisition Scenario Report

http://www.reve= redata.com/research/reports.shtml

1-866-REVERE9

May 04 2007 18:08 EDT

Mergers and Acquisition Scenario Report

Summary

Other Scenarios:

  • TOC - C=20
  • TOC - IBM=20
  • C - RTRSY=20
  • IBM - RTRSY=20
Buyer: The Thomson Corporation (USA) (TOC) Last Price: 43.45 Market Cap.: 27.81B
Target: Reuters Group PLC (ADR) (RTRSY) Last Price: 74.76 Market Cap.: 15.68B

Lines of Business Summary:

  • The Thomson Corporation (USA) (TOC) = competes in=20 5 industries and 71 product/service groups=20
  • Reuters Group PLC (ADR) (RTRSY) = competes in=20 3 industries and 21 product/service groups=20
  • A combined entity will have 8% Product/Service Group = overlap=20
  • The Thomson Corporation (USA) (TOC) = has=20 1 and Reuters Group PLC (ADR) (RTRSY) has=20 1 suppliers that rely on a material % of their business. They = share=20 0 in common.

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
3D""=20 = *Finance = = 1,293
3D""=20 = Investment = = 122
3D""=20 = *Healthcare =   873
3D""=20 = Healthcare Services =   155
3D""=20 = Outsourced Services =   65
3D""=20 = *Media 3D""=20 3D""=20 144
3D""=20 = Electronic Media 3D""=20 3D""=20 41
3D""=20 = Entertainment/Programming   = 40
3D""=20 = Print =   30
3D""=20 = *Technology = = 1,218
3D""=20 = Software = = 305
3D""=20 = Technology Services =   320
3D""=20 = Services =   395
3D""=20 = Consumer Services =   40

3D""=20 - = Sector=20 Pure-Plays. Denotes that the company is focused in the selected sector = and=20 generates nearly all earnings in the sector/product area specified.

3D""=20 - = Sector=20 Participation. Denotes that the company develops products in this line = of=20 business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of = Business
Buyer (Total: 320)
  • Dialog Corporation - Dialog1=20
  • Dialog Corporation - DialogPro=20
  • Dialog Corporation - DialogOpenAccess=20
  • Dialog Corporation - Dialog SourceOne
Target (Total: 78)
  • Reuters News Service=20
  • Reuters Pictures=20
  • Reuters Photos=20
  • Reuters Graphics
Buyer
  • Thomson Transaction Services=20
  • Centre for Medicines Research International Limited (CMR=20 International)=20
  • Solucient Clinical/Operational/Market Insight Services=20
  • Derwent GENESEQ
Target
  • Lipper, Inc. - Lipper Research Series=20
  • Life!=20
  • Financial Report=20
  • Reuters Television and Video Service =

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 10)
  • Onstream Media Corp (ONSM)=20
  • Broadcom Corporation (BRCM)=20
  • Advanced Micro Devices, Inc. (AMD)=20
  • Silicon Laboratories (SLAB) =
Target (Total: 14)
  • Tibco Software Inc. (TIBX)=20
  • BT Group plc (ADR) (BT)=20
  • MasterCard Incorporated (MA)=20
  • SAVVIS, Inc. (SVVS) =
Buyer (Total: 2)
  • FactSet Research Systems Inc. (FDS)=20
  • US Dataworks, Inc. (UDW) =
Target (Total: 18)
  • Citigroup Inc. (C)=20
  • JPMorgan Chase & Co. (JPM)=20
  • Barclays PLC (ADR) (BCS)=20
  • ABN AMRO Holding N.V. (ADR) (ABN)=20

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 32,375 16,302
Revenue Per Employee 206,743.1 313,560.8
Total Revenue 1,669.0 2,565.4
Total Expenses 1,443.0 2,298.7
Other=20 Revenue3D"" 0.0 0.0
Cost of=20 Revenue = 1,267.0 2,342.5
SG&A=20 Expense3D"" 0.0 0.0
Research=20 & Development3D"" 0.0 0.0
Other = Operating=20 Expense = 0.0 -43.8
Operating=20 Income3D""=20 = 226.0 266.7
Unusual = Income = 0.0 0.0
LT Debt to = Capital = 23.76 75.18
Fwd=20 P/E = 26.03 24.25
Fwd=20 P/Rev = 3.59 2.38
Book Value 10,510.0 342.3
Curr=20 Portion of LTD/Cap Lease = 661.0 0.0

Individual Company=20 Summary

Focused

Buyer

Focused (3D""=20): = *Media=20 > Electronic Media

Target

Focused (3D""=20): = *Media=20 > Electronic Media > Financial Data

Revenue/Earnings=20 Summary

Buyer
Fiscal Year:
Quarter:
2007
*  Dec =
2006
Dec
2005
Dec
Q1
Rev. (M)
EPS
1,669.0
0.27
1,507.0
0.12
1,769.0
0.06
Q2
Rev. (M)
EPS
  
2,101.0
0.33
1,966.0
0.44
Q3
Rev. (M)
EPS
  
2,430.0
0.66
2,304.0
0.51
Q4
Rev. (M)
EPS
  
5,134.0
1.64
2,404.0
0.39
FY
Rev. (M)
EPS
*  7,786.9 =
1.68
6,641.0
1.76
6,173.0
1.44
*  -=20 Estimates
Target
Fiscal Year:
Quarter:
2006
*  Dec =
2006
Dec
2005
Dec
Q1
Rev. (M)
EPS
      
Q2
Rev. (M)
EPS
  
2,541.5
0.85
2,266.9
1.05
Q3
Rev. (M)
EPS
      
Q4
Rev. (M)
EPS
  
2,565.4
1.93
2,527.6
2.71
FY
Rev. (M)
EPS
*  5,203.0 =
2.43
5,107.0
2.77
4,794.5
3.29
*  -=20 Estimates

Business=20 Description

Buyer

The Thomson Corporation (Thomson) is an information service provider. = It=20 operates through three groups. Thomson Legal & Regulatory is a = provider of=20 information and software-based solutions for legal, tax, accounting,=20 intellectual property, compliance and other business professionals, as = well as=20 government agencies. Thomson Financial is a provider of products and = integration=20 services to financial and technology professionals in the corporate, = investment=20 banking, institutional, retail wealth management and fixed income = sectors of the=20 global financial community. Thomson Scientific & Healthcare is a = provider of=20 information and services to researchers, physicians and other = professionals in=20 the healthcare, academic, scientific, corporate and government = marketplaces. In=20 March 2007, it acquired CrossBorder Solutions. In March 2007, The Wicks = Group of=20 Companies, L.L.C. announced that its affiliate, Penn Foster Holdings, = LLC,=20 completed the acquisition of Education Direct, Inc., from = Thomson.

Target

Reuters Group PLC (Reuters) is a provider of content and transaction=20 services. It operates through four business divisions: Sales & = Trading,=20 which offers advanced desktop financial information products, analytics = and=20 trading systems designed for use by traders and sales people; Research = &=20 Asset Management, which offers in-depth information, analysis and = research=20 products designed mainly for use by people making investment decisions;=20 Enterprise, which offers information feeds and tools designed for use by = machines to help its customers automate their business, and Media, which = offers=20 news for use by professional publishers, multimedia Websites and mobile=20 information services. Reuters runs a multimedia news operation and = produces=20 250,000 news stories in 19 languages, 40,000 pictures and over 4,000 = video=20 stories each month. It aggregates price information collected from = contributors=20 for many asset classes and it distributes trade data published by = exchanges and=20 other trading venues.

Deal Summary

Scenario 1:=20
Buyer's Share Price: 43.45; Target's Share Price: = 74.76;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 2:=20
Buyer's Share Price: 43.45; Target's Share Price: = 82.24;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 3:=20
Buyer's Share Price: 43.45; Target's Share Price: = 89.71;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 4:=20
Buyer's Share Price: 43.45; Target's Share Price: = 97.19;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;

Deal Scenarios Analytics

  Scenario 1 Scenario 2 Scenario 3 Scenario 4
Financial Analysis
Financing Value 16.07B 17.68B 19.29B 20.89B
Required for deal
Stock 16.07B 17.68B 19.29B 20.89B
Cash 0 0 0 0
Debt 0 0 0 0
Shares
New Shares to be Issued 369.90M 406.89M 443.88M 480.87M
New Shares Outstanding F.D 1.01B 1.05B 1.09B 1.12B
Taxes
New Tax Rate 0.10 0.10 0.10 0.10
EPS
Old FD EPS 1.48 1.48 1.48 1.48
New FD EPS 1.49 1.44 1.39 1.35
Goodwill and Synergy
Goodwill/Intangibles 15.73B 17.34B 18.94B 20.55B
Total Synergy Required for Accretion 0 41.21M 101.59M 161.96M
Pro Forma % Ownership
Buyer's 63.51% 61.27% 59.19% 57.24%
Seller's 36.49% 38.73% 40.81% 42.76%
Accretion/Dilution
Per Share 0.02 -0.04 -0.08 -0.13
% Change 1.16% -2.40% -5.72% -8.82%
Total Consideration
Cash as % of Total Consideration to increase $0.01 EPS        
Synergy to increase $0.01 EPS 11.21M 11.62M 12.03M 12.44M

Key Ratios

  Buyer Target Scenario 1 Scenario 2 Scenario 3 Scenario 4
Gross Margin=20 % = 28.91 8.38 20.11 20.11 20.11 20.11
Operating=20 Margin % = 18.74 9.98 14.98 14.98 14.98 14.98
Quick = Ratio = 0.41 0.65 0.48 0.48 0.48 0.48
Current=20 Ratio = 0.76 0.66 0.73 0.73 0.73 0.73
Coverage = Ratio = -0.17 -0.07 0.15 0.15 0.15 0.15
Total Assets 20,038.0 3,821.3 23,859.3 23,859.3 23,859.3 23,859.3
Return on Equity % 8.79 170.35 16.77 16.77 16.77 16.77
Return on Assets % 4.61 15.26 6.23 6.23 6.23 6.23
Cash+ ST Inv. = Per=20 Share3D"" 0.54 3.14 0.91 0.91 0.91 0.91
Total Debt 4,527.0 1,367.3 5,233.3 5,233.3 5,233.3 5,233.3
Total Debt to Equity % 43.07 399.42 48.22 48.22 48.22 48.22
Total Debt to Tangible Equity % n/a n/a -24.22 -24.22 -24.22 -24.22
Debt = to Asset=20 % = 22.59 35.78 21.93 21.93 21.93 21.93

Product = Details

Sector Buyer Target
3D""=20 = *Finance = =20
3D""=20 = Investment = =20
3D""=20 = Asset Management and Financial Advisory=20
The Asset Management and Financial Advisory = branch=20 profiles services and companies involved in directly managing = personal and=20 institutional portfolios and investment instruments, as well as = advisory=20 services like retirement and financial planning, asset allocation, = and=20 risk assessment. Banks are generally not attached to the Asset = Management=20 and Financial Advisory branch unless their asset management or = financial=20 advisory subsidiaries clearly operate with a significant level of=20 independence from the company's core banking = operations.
 =  
3D""=20 = Securities Sales and Trading=20
The Investment sector encompasses financial = products and=20 services offered by financial institutions on behalf of clients. = Services=20 included asset management and financial advisory, investment = banking and=20 corporate finance, and securities sales and trading.
   =20
3D""=20 = *Healthcare =  
3D""=20 = Healthcare Services =  
3D""=20 = Support Services=20
The Support Services Subsector is comprised of = companies=20 that provide non-medical services for managing, enhancing, = facilitating,=20 and enabling the healthcare delivery process.
 =  
3D""=20 = Outsourced Services =  
3D""=20 = Drug Discovery Services=20
The Drug Discovery Services Subsector includes = companies=20 that provide biopharmaceutical companies with novel biological = targets and=20 drug leads.
 =  
3D""=20 = *Media 3D""=20 3D""=20
3D""=20 = Electronic Media 3D""=20 3D""=20
3D""=20 = Content Syndicators=20
Companies that provide proprietary or aggregated = information via the internet by means of automated data feed or = licensed=20 access. Frequently includes multimedia, as well as = streaming/cached video=20 content.
   =20
3D""=20 = Electronic Publishers=20
Companies engaged in the distribution of = electronic media=20 to end users via the internet. These companies either produce and = publish=20 their own content, or license information and features from = content=20 syndicators.
 = =20
3D""=20 = Financial Data=20
Services offered electronically which provide = research and=20 execution capability on a variety of financial instruments, = including=20 equities, derivatives, and bonds. Content offered via datafeeds = are placed=20 here also.
 = 3D""=20
3D""=20 = Entertainment/Programming   =20
3D""=20 = Television, Film and Video=20
Companies involved in the production, = post-production, and=20 distribution of Motion Pictures and Television = programming.
   =20
3D""=20 = Print =  
3D""=20 = Advertising=20
The Print Advertising subsector contains = publications such=20 as catalogs, classifieds, and directories that promote products or = services that are intended to be bought by companies and/or=20 consumers.
 =  
3D""=20 = Publishing=20
Publications of news/information/entertainment = content,=20 which include paper and electronic format. Publications such as = books,=20 magazines, newspapers, and trade journals are captured in this = area.=20 Largely all of these companies also transmit some portion of their = content=20 via the internet.
 =  
3D""=20 = *Technology = =20
3D""=20 = Software = =20
3D""=20 = Enterprise Management=20
Software designed to maximize the efficiency and = productivity with which the enterprise is run. Includes Customer=20 Relationship Management (CRM) and Enterprise Resource Planning = (ERP)=20 software.
 = =20
3D""=20 = Home/Office=20
Personal productivity and entertainment software = targeted=20 toward consumer and business users.
 =  
3D""=20 = Industry-Specific=20
Software that has functionality specific to a = vertical=20 industry.
 = =20
3D""=20 = Technology Services =  
3D""=20 = Information Technology (IT)=20
IT Services includes the design, development,=20 implementation, support, or management of computer-based = information=20 systems particularly software applications, networking equipment, = and=20 computer hardware. This also includes services specifically = tailored=20 towards all aspects of computing, data storage, communications, = and=20 services concerning the development and deployment of applications = and=20 systems for business that cover the entire business = enterprise.
 =  
3D""=20 = Services =  
3D""=20 = Consumer Services =  
3D""=20 = Educational Services=20
Includes for-profit educational institutions, = such as=20 primary/secondary schools, post-secondary schools, and related = support=20 services.
 =  

3D""=20 - = Sector=20 Pure-Plays. Denotes that the company is focused in the selected sector = and=20 generates nearly all earnings in the sector/product area specified.

3D""=20 - = Sector=20 Participation. Denotes that the company develops products in this line = of=20 business.

Product = Details

Sector Buyer Target
3D""=20 = *Finance = =20
3D""=20 = Investment = =20
3D""=20 = Asset Management and Financial Advisory =  
3D""=20 = Global Custody/Securities Processing=20
Global Custody/Securities Processing includes a = range of=20 outsourced services offered to other financial institutions. = Mutual funds,=20 investment advisors, banks, and insurance companies often = outsource their=20 back and middle office responsibilities like securities custody, = account=20 settlement, and fund accounting and administration.

Buyer Products:

  • Thomson Transaction Services
=  
3D""=20 = Securities Sales and Trading   =20
3D""=20 = Research   =20
3D""=20 = Economic Research=20
Services provided by investment firms that = involve the=20 gathering of statistical data and study of general trends in the=20 economy.

Target Products:

  • Lipper, Inc. - Lipper Research Series
  =20
3D""=20 = Securities Research=20
Services provided by investment firms that = involve the=20 analysis of particular securities, commodities and = industries.

Target Products:

  • Lipper, Inc. - Lipper Research Series
  =20
3D""=20 = *Healthcare =  
3D""=20 = Healthcare Services =  
3D""=20 = Support Services =  
3D""=20 = Consulting=20
Services providing advice, assistance, and = information to=20 a wide range of healthcare companies, including pharmaceutical, = medical=20 devices, and health services companies.

Buyer Products:

  • Centre for Medicines Research International Limited (CMR=20 International)=20
  • Solucient Clinical/Operational/Market Insight Services=20
=  
3D""=20 = Outsourced Services =  
3D""=20 = Drug Discovery Services =  
3D""=20 = Target Discovery/Validation =  
3D""=20 = Databases =  
3D""=20 = Genomics =  
3D""=20 = Human=20
Genomic databases that contain human genetic=20 information.

Buyer Products:

  • Derwent GENESEQ
=  
3D""=20 = *Media 3D""=20 3D""=20
3D""=20 = Electronic Media 3D""=20 3D""=20
3D""=20 = Content Syndicators   =20
3D""=20 = News=20
Syndication of news to various websites.

Target Products:

  • Reuters News Service
  =20
3D""=20 = Video/Images   =20
3D""=20 = Still Images=20
Includes services offering photographic and = other=20 pictorial content, licensed for use by other media = organizations.

Target Products:

  • Reuters Pictures=20
  • Reuters Photos=20
  • Reuters Graphics
  =20
3D""=20 = Video=20
Video syndicators provide websites with the = ability to=20 distribute news and information via streaming video.

Target Products:

  • Health Video Online=20
  • Financial Video Online=20
  • Entertainment Video Online
  =20
3D""=20 = Electronic Publishers = =20
3D""=20 = Industry Specific = =20
3D""=20 = Energy=20
Comprised of electronic publishing companies = that provide=20 updates on the energy industry, which include the oil, gas, coal, = fossil=20 fuel industries, etc.

Buyer Products:

  • Dialog Corporation - Dialog1=20
  • Dialog Corporation - DialogPro=20
  • Dialog Corporation - DialogOpenAccess=20
  • Dialog Corporation - Dialog SourceOne=20
  • Dialog Corporation - DialogSelect
=  
3D""=20 = Government/Public Sector=20
Comprised of web sites that provide information = to=20 different arms of the government such as defense, judicial, = etc.

Buyer Products:

  • Dialog Corporation - DialogOpenAccess=20
  • Dialog Corporation - Dialog SourceOne=20
  • Dialog Corporation - DialogWeb=20
  • Dialog Corporation - DialogSelect
=  
3D""=20 = Healthcare = =20
3D""=20 = Diseases/Ailments=20
Internet sites that provide general and/or = in-depth=20 information on disease or bodily disorders to doctors or patients. = These=20 sites are often used as reference sources and for the general = education of=20 individuals.

Buyer Products:

  • NexCura=20
  • Drugdex=20
  • AHC Media
=  
3D""=20 = Drug Development=20
Destination sites that provide information on = drugs going=20 throughout the drug development stages: patient, clinical, or=20 regulatory.

Buyer Products:

  • CenterWatch.com=20
  • IHI Liquent-IDRAC=20
  • Drugs in Clinical Trials Database=20
  • Current Drugs IDdb=20
  • Micromedex
=  
3D""=20 = Drugs/Medicine=20
Databases that provide a variety of medical = information on=20 new drugs and medicines.

Buyer Products:

  • Dialog Corporation - Dialog1=20
  • Dialog Corporation - DataStar=20
  • Dialog Corporation - DialogSelect=20
  • Dialog Corporation - DialogOpenAccess

Target Products:

  • ReutersHealth.com
= =20
3D""=20 = General Healthcare=20
Web sites that provide information on the = medical industry=20 without focusing on a specific subject. The information found in = these=20 sites can be on personal health, nutrition and exercise = tips.

Buyer Products:

  • PDR.Net
=  
3D""=20 = Personal Health=20
Web sites that provide healthcare information, = including=20 columns and articles regarding health issues, information on = diseases or=20 drugs, and online healthcare advice.

Buyer Products:

  • PDRHealth.com

Target Products:

  • ReutersHealth.com
= =20
3D""=20 = Poisons=20
Information websites that provide information on = poisons.=20 These sites can be used by professionals or people who need = information on=20 this subject.

Buyer Products:

  • Poisindex
=  
3D""=20 = Surgical Procedures=20
Websites that provide information about surgical = procedure=20 to professionals and everyday web users.

Buyer Products:

  • Emergindex=20
  • AHC Media
=  
3D""=20 = Law=20
Web sites that provide access to information on = the law=20 industry. The information can be used by individuals or legal=20 professionals.

Buyer Products:

  • WestLaw.com=20
  • Taxnet.pro=20
  • FindLaw.com
=  
3D""=20 = Sciences=20
Comprised of web sites that provide information = to=20 science-focused industries, including biology, chemistry, and = physics.=20 Usually, these web sites are an option to a hardcopy of a trade = journal in=20 that one can get the information in magazine form or on the=20 Internet.

Buyer Products:

  • ISI Web of Science=20
  • BIOSIS=20
  • Dialog Corporation - DataStar=20
  • Dialog Corporation - DialogClassicWeb=20
  • ISI Journal Citation Reports=20
  • ScholarOne Manuscript Central=20
  • ScholarOne Abstract Central=20
  • ScholarOne Proceedings Central=20
  • Dialog Corporation - DialogClassic=20
  • Dialog Corporation - Dialog1
=  
3D""=20 = Technology=20
Web sites that provide information on the = technology=20 industry, including communications, hardware, semiconductors, and=20 software.

Buyer Products:

  • Dialog Corporation - DialogSelect
=  
3D""=20 = Reference = =20
3D""=20 = Healthcare=20
Healthcare news syndicators provide web sites = with news=20 and information that deals with the branches of the healthcare = industry.=20 The information can be on specific diseases, new drugs/medicines,=20 alternative therapies, etc.

Target Products:

  • ReutersHealth.com
  =20
3D""=20 = Intellectual Property=20
Web sites which provide information regarding = the=20 ownership rights of inventions, trademarks, patents, works of art, = literature, images, etc. that are used for the purpose of = commerce.

Buyer Products:

  • Thomson CompuMark=20
  • IHI MicroPatent, LLC - Trademark.com=20
  • IHI MicroPatent, LLC - PatentWeb=20
  • Information Holdings Inc. - Master Data Center IP Master=20
  • Dialog Corporation - DialogWeb=20
  • Dialog Corporation - DialogSelect=20
  • Dialog Corporation - DialogOpenAccess=20
  • Dialog Corporation - Dialog1=20
  • Dialog Corporation - Dialog SourceOne=20
  • Delphion Research=20
  • Thomson & Thomson - SAEGIS=20
  • Thomson Patent Store=20
  • IHI MicroPatent, LLC - File Histories=20
  • IHI MicroPatent, LLC - Aureka=20
  • Dialog Corporation - DialogClassic
=  
3D""=20 = Financial Data = 3D""=20
3D""=20 = Execution and Quote Platforms=20
Offered to large-volume trading professionals, = including=20 active trader data, such as real-time quotes, advanced analytics, = and=20 access to trade execution.

Buyer Products:

  • TradeWeb

Target Products:

  • Reuters Xtra=20
  • Reuters Trader=20
  • Reuters Real-Time Data=20
  • Reuters Deal Tracker=20
  • FX on Reuters=20
  • Spot Matching on Reuters=20
  • Forward Matching on Reuters=20
  • Reuters Connect=20
  • Reuters Order Routing
= =20
3D""=20 = Financial Reference Data=20
Financial market reference data offered to = investment=20 bankers and financial information professionals, typically = aggregated in a=20 data feed, including pricing, financial ratios, SEC filings, = valuation=20 metrics, and other data.

Buyer Products:

  • Thomson ONE=20
  • Baseline=20
  • Fund Advisor=20
  • First Call=20
  • Freeman Imputed Fee Data

Target Products:

  • Reuters Investor=20
  • Reuters Knowledge=20
  • Reuters Data Feeds=20
  • Reuters NewsScope Archive=20
  • Reuters Pricing and Reference Data=20
  • Reuters Fundamentals=20
  • Reuters DataScope
= =20
3D""=20 = Institutional Financial Content and Research=20
Research reports and other content targeted = towards=20 institutional clients, including fund managers, buy-side analysts, = and=20 other financial professionals.

Buyer Products:

  • Dialog Corporation - DataStar=20
  • Thomson Research=20
  • Dialog Corporation - Dialog SourceOne=20
  • Dialog Corporation - Dialog TradStat=20
  • Worldscope Fundamentals=20
  • Sharewatch DataFeeds=20
  • Investext=20
  • Thomson Investor Tools=20
  • SDC Platinum=20
  • Investment Benchmark Reports=20
  • Dialog Corporation - DialogPro=20
  • Dialog Corporation - Dialog1=20
  • Acquisitions Monthly=20
  • Thomson ONE=20
  • Buyouts=20
  • Capital Markets Consulting=20
  • BlockDATA

Target Products:

  • Reuters StockVal=20
  • Lipper, Inc. - Hindsight=20
  • Reuters Investor=20
  • Lipper, Inc. - Lipper Research Series
= =20
3D""=20 = Entertainment/Programming   =20
3D""=20 = Television, Film and Video   =20
3D""=20 = Production   =20
3D""=20 = Television   =20
3D""=20 = Domestic   =20
3D""=20 = Educational=20
Shows intended to be used for classroom or = in-home=20 learning.

Target Products:

  • Life!=20
  • Financial Report
  =20
3D""=20 = News/News Magazine=20
Shows that present current news events. These = shows often=20 have reporters out in the field, along with interviews from the = world of=20 entertainment, sports and finance.

Target Products:

  • Reuters Television and Video Service=20
  • Reuters Financal Report=20
  • Reuters World News Service
  =20
3D""=20 = Sports=20
Shows that broadcast or report on sporting = events.

Target Products:

  • Reuters Sports News Service
  =20
3D""=20 = International   =20
3D""=20 = Americas=20
Companies that produce television shows for the=20 Americas.

Target Products:

  • Reuters Television and Video Service
  =20
3D""=20 = Asia/Pacific=20
Companies that produce television shows for the=20 Asia/Pacific region.

Target Products:

  • Reuters Television and Video Service=20
  • The Asia News Service
  =20
3D""=20 = Europe=20
The Europe sector is comprised of companies that = produce=20 television shows that air throughout Europe in different = dialects.

Target Products:

  • Reuters Television and Video Service=20
  • German News Service
  =20
3D""=20 = Middle East/Africa=20
Companies that produce television shows for the = Middle=20 East/Africa region.

Target Products:

  • Africa Daily=20
  • Africa Journal
  =20
3D""=20 = Print =  
3D""=20 = Advertising =  
3D""=20 = Directories =  
3D""=20 = Domestic =  
3D""=20 = Business to Business=20
Directories for businesses to use to find = information=20 about other businesses.

Buyer Products:

  • ACH Participant Directory=20
  • American Financial Directory=20
  • Thomson Bank Directory=20
  • Thomson Credit Union Directory=20
  • Thomson North American Financial Institutions Directory=20
  • Thomson Regulation CC Directory=20
  • Thomson Savings Directory=20
  • Directory of M&A Intermediaries=20
  • Directory of Limited Partners=20
  • Directory of Venture-Backed Companies=20
  • Nelson Information's Directories=20
  • Nelson Information's World's Best Money Managers=20
  • European Biotechnology VC Directory=20
  • Card Industry Directory=20
  • Mortgage Industry Directory=20
  • State of the Clinical Trials Industry=20
  • Asset Securitization Directory=20
  • Corporate Syndicate Personnel Directory=20
  • Directory of Buyout Financing Sources=20
  • Medical Economics Company - RN CareerSearch=20
  • Pratt's Guide to Private Equity Sources=20
  • ABA Directory of Trust Banking=20
  • ABA Financial Institutions Directory
=  
3D""=20 = International =  
3D""=20 = Americas=20
Directories published in Canada, Mexico, and = Central/South=20 America.

Buyer Products:

  • U.S. and Canadian Biotechnology VC Directory=20
  • Thomson Directories Ltd.
=  
3D""=20 = Asia/Pacific=20
The Directories sector is comprised of = publications in the=20 Asia/Pacific region containing lists of names, addresses and other = information such as telephone numbers that are usually listed=20 alphabetically and/or by class.

Buyer Products:

  • The Thomson Financial Handbook
=  
3D""=20 = Europe=20
The Directories sector is comprised of = publications in the=20 continent of Europe containing lists of names, addresses and other = information such as telephone numbers that are usually listed=20 alphabetically and or by class.

Buyer Products:

  • European Biotechnology VC Directory
=  
3D""=20 = Publishing =  
3D""=20 = Books =  
3D""=20 = Domestic =  
3D""=20 = Fiction=20
Books with fictional content.

Buyer Products:

  • Thomson Gale - Five Star Publishing
=  
3D""=20 = Non-Fiction =  
3D""=20 = Dictionaries=20
Dictionaries in general and specific fields, = including=20 translation, science, law, medical, and engineering. Also includes = Thesaurus books.

Buyer Products:

  • Black's Law Dictionary
=  
3D""=20 = Educational=20
Books and study aids with content that informs = or provides=20 knowledge.

Buyer Products:

  • Thomson Gale - Thorndike Press=20
  • Thomson Gale - St. James Press=20
  • Thomson Wadsworth=20
  • Thomson South-Western=20
  • Thomson Schirmer=20
  • Thomson Gale - Lucent Books=20
  • Thomson Gale - Kidhaven Press=20
  • Thomson Heinle=20
  • Thomson Delmar Learning=20
  • Thomson Course Technology=20
  • Thomson Custom Publishing=20
  • Thomson Gale - Sleeping Bear Press=20
  • Thomson Nelson=20
  • Thomson Brooks/Cole
=  
3D""=20 = Industry Specific =  
3D""=20 = Business/Finance=20
Published Encyclopedias used as a reference = guide for the=20 Business/Financial institutions.

Buyer Products:

  • Macmillan Reference USA
=  
3D""=20 = General Education=20
The General Educational sub sector is comprised = of=20 encyclopedias used as a reference by students and or professionals = searching for non-industrial information.

Buyer Products:

  • Thomson Gale=20
  • Thomson Gale - Charles Scribner's Sons=20
  • Thomson Gale - UXL
=  
3D""=20 = Medical=20
Published Encyclopedias used as a reference = guide for the=20 medical industry.

Buyer Products:

  • Hospital Handbook on Smallpox Vaccination=20
  • AHC Media=20
  • PDR for Nutritional Supplements=20
  • PDR for Ophthalmic Medicines=20
  • PDR Medical Dictionary=20
  • PDR Pharmacopoeia Pocket Dosing Guide=20
  • PDR Supplements=20
  • Red Book=20
  • The CenterWatch Directory of Drugs in Clinical Trials=20
  • Physicians' Desk Reference=20
  • PDR for Herbal Remedies=20
  • PDR Guide to Terrorism Response=20
  • The ADA/PDR Guide to Dental Therapeutics=20
  • The PDR/Johns Hopkins ABX Guide=20
  • PDR Lab Advisor=20
  • PDR Guide to Drug Interactions, Side Effects, & = Indications=20
  • PDR/Johns Hopkins ABX Guide: Diagnosis & Treatment of = Infectious=20 Diseases=20
  • PDR Drug Guide for Mental Health Professionals=20
  • Hyperlipidemia-A PDR Clinical Handbook=20
  • PDR for Herbal Medicines=20
  • PDR for Nonprescription Drugs and Dietary Supplements=20
=  
3D""=20 = Science/Technology=20
Published Encyclopedias used as a reference = guide for the=20 entire scientific community.

Buyer Products:

  • Thomson Gale - Twayne Publishers=20
  • Thomson Gale - Greenhaven Press=20
  • Thomson Delmar Learning=20
  • Thomson Course Technology
=  
3D""=20 = Trade=20
Books on business or tailored toward people = working in or=20 associated with particular industries.

Buyer Products:

  • AHC Media=20
  • BAR/BRI West=20
  • Thomson Delmar Learning=20
  • Foundation Press=20
  • Sweet & Maxwell=20
  • Thomson & Thomson=20
  • Thomson West
=  
3D""=20 = International =  
3D""=20 = Americas=20
Companies that publish books in Canada, Mexico, = and=20 Central/South America.

Buyer Products:

  • Thomson Learning Iberoamerica=20
  • Carswell=20
  • Diccionario de Especialidades Farmaceuticas=20
  • Nelson=20
  • IOB=20
  • Diccionario de Productos OTC=20
  • Guia de Proveedores y Servicios en el Area de Salud=20
  • Thomson Nelson=20
  • La Ley=20
  • Thomson Gale - Five Star Publishing=20
  • Les Edition Yvon Blais
=  
3D""=20 = Asia/Pacific=20
The Asia/Pacific sector is comprised of = companies that=20 publish books throughout the Asia/Pacific region.

Buyer Products:

  • Thomson Learning Asia=20
  • Lawbook Co.=20
  • Westlaw Australia=20
  • Sweet & Maxwell=20
  • Brookers=20
  • CPD=20
  • Thomson Learning Australia
=  
3D""=20 = Europe=20
The Europe sector is comprised of companies that = publish=20 books in Western and Eastern Europe, the Middle East, etc.

Buyer Products:

  • Aranzadi=20
  • BAR/BRI=20
  • Thomson Gale - K.G. Saur=20
  • Sweet & Maxwell=20
  • Wila Verlag Publishings=20
  • Thomson Gale - Oceano Grupo=20
  • Thomson Nelson=20
  • ELLIS Publications=20
  • Thomson Gale - Graham & Whiteside=20
  • Thomson Learning Iberoamerica=20
  • Thomson Learning EMEA
=  
3D""=20 = Trade Publications =  
3D""=20 = Newsletters =  
3D""=20 = Domestic =  
3D""=20 = Finance=20
The Finance sub sector is comprised of = newsletters that=20 update professionals in the finance industry.

Buyer Products:

  • Private Equity Week=20
  • Private Placement Letter=20
  • Buyouts Newsletter=20
  • International Financing Review=20
  • IPO Reporter
=  
3D""=20 = Medical=20
The Medical sub sector is comprised of = newsletters that=20 update subscribers in the healthcare industry.

Buyer Products:

  • Urgent Care Alert=20
  • Travel Medicine Advisor=20
  • Biomedical Business & Technology=20
  • Clinical Trials Administrator=20
  • Current Issues in the Treatment of Rheumatic Diseases=20
  • Practical Summaries in Acute Care=20
  • BioWorld Phase III Report=20
  • CenterWatch Monthly Newsletter=20
  • AIDS Alert=20
  • Alternative Medicine Alert=20
  • Alternative Therapies in Women's Health=20
  • Cardiovascular Device Update=20
  • Case Management Advisor=20
  • CenterWatch Weekly=20
  • Clinical Cardiology Alert=20
  • Clinical Oncology Alert=20
  • Contraceptive Technology Update=20
  • Critical Care Alert=20
  • Dental Implantology Update=20
  • Drug Formulary Review=20
  • ED Legal Letter=20
  • ED Management=20
  • ED Nursing=20
  • Hospital Medicine Alert=20
  • Emergency Medicine Reports=20
  • Healthcare Benchmarks and Quality Improvement=20
  • Healthcare Risk Management=20
  • Hospice Management Advisor=20
  • Hospital Access Management=20
  • Hospital Case Management=20
  • Hospital Employee Health=20
  • Hospital Home Health=20
  • Hospital Infection Control=20
  • Hospital Peer Review=20
  • Infectious Disease Alert=20
  • Internal Medicine Alert=20
  • IRB Advisor=20
  • JobWatch=20
  • Medical Ethics Advisor=20
  • Neurology Alert=20
  • OB/GYN Clinical Alert=20
  • Occupational Health Management=20
  • Patient Education Management=20
  • Pediatric Emergency Medicine Reports=20
  • Primary Care Reports=20
  • Research Practitioner=20
  • Same-Day Surgery=20
  • State Health Watch=20
  • Trauma Reports=20
  • Bariatric Medicine Alert
=  
3D""=20 = Trade Journals =  
3D""=20 = Domestic =  
3D""=20 = Business/Financial=20
Publications produced for those involved in = banking,=20 economics, investments and the financial industry.

Buyer Products:

  • Extel Survey=20
  • International Securitisation Report=20
  • IFR Asia=20
  • European Venture Capital Journal=20
  • Acquisitions Monthly=20
  • Project Finance International=20
  • Venture Capital Journal
=  
3D""=20 = Healthcare =  
3D""=20 = Medical=20
Publications produced for individuals in the = medical=20 profession. This includes all branches of medical community and = all=20 disciplines within the medical field, such as psychiatry, = oncology,=20 etc.

Buyer Products:

  • PDR Monthly Prescribing Guide=20
  • Current Opinion in Drug Discovery and Development=20
  • How to Find & Secure Clinical Grants =
=  
3D""=20 = Law=20
Publications produced for those involved in the = business=20 of law, legal or legislative matters.

Buyer Products:

  • Thomson RoundHall - Annual Review of Irish Law =
=  
3D""=20 = International =  
3D""=20 = Europe =  
3D""=20 = Business/Financial=20
Publications produced for those in said = territory involved=20 in the business of banking, economics, investments and the = financial=20 industry.

Buyer Products:

  • European Venture Capital Journal
=  
3D""=20 = *Technology = =20
3D""=20 = Software = =20
3D""=20 = Enterprise Management = =20
3D""=20 = Content Management   =20
3D""=20 = Enterprise Search=20
Software which allows enterprises to gather and = organize=20 specific information located within their systems = electronically.

Target Products:

  • ClearForest Corp.
  =20
3D""=20 = Enterprise Resource Planning (ERP) =  
3D""=20 = Business Planning/Control =  
3D""=20 = Project Management=20
Software that is designed specifically to manage = project=20 workflow and organization. Includes functions such as task = assignment,=20 progress reporting, information dissemination, and project = costing.

Buyer Products:

  • Elite Information Group - WorkFlow=20
  • Elite Information Group - Project and Resource Manager=20
=  
3D""=20 = Financial/Compliance =  
3D""=20 = Compliance=20
Software which assists companies in complying = with various=20 compliance requirements, including, local, national, = international, sector=20 specific, and internal. Examples Include Sarbanes Oxley financial=20 reporting compliance, and ISO quality standards.

Buyer Products:

  • CrossBorder VeriFIN 48=20
  • CrossBorder Compliance
=  
3D""=20 = Financial Management/Automation=20
ERP Software used for financial management tasks = such as=20 budgeting, strategic planning, and reporting. Includes enterprise=20 procurement software.

Buyer Products:

  • CrossBorder Update=20
  • Elite Information Group - Profitability Manager=20
  • CrossBorder FasTrac 109=20
  • ConjecSure
=  
3D""=20 = General Ledger/Accounting=20
Software that performs general accounting = functions, such=20 as balance sheet, income, and cash flow calculations.

Buyer Products:

  • Elite Information Group - General Ledger=20
  • Elite Information Group - Express=20
  • Elite Information Group - Accounts Payable =
=  
3D""=20 = Payment Processing=20
Software that manages payment processing=20 functionality.

Buyer Products:

  • Elite Information Group - Image Processing Manager=20
  • Elite Information Group - Billing Manager=20
  • Elite Information Group - Collections Manager=20
  • Elite Information Group - Paperless Proforma =
=  
3D""=20 = Human Resources =  
3D""=20 = Benefit/Payroll Management=20
Software that aids in the management of the = workforce,=20 performing functions such as benefit and payroll management.

Buyer Products:

  • Architec(k)
=  
3D""=20 = Time Tracking/Scheduling=20
Software used to schedule, record, and report on = employee=20 work times and activities.

Buyer Products:

  • Elite Information Group - TimeTrax
=  
3D""=20 = Home/Office =  
3D""=20 = Educational =  
3D""=20 = Field Specific =  
3D""=20 = Finance=20
CD ROMs that offer financial information, much = like those=20 found on magazines, news sources or databases.

Buyer Products:

  • MicroMash Continuing Professional Education (CPE) Series=20
=  
3D""=20 = Intellectual Property=20
CD-ROMs which provide information regarding the = ownership=20 rights of inventions, works of art, literature, images, etc. that = are used=20 for the purpose of commerce.

Buyer Products:

  • Wila Verlag
=  
3D""=20 = Medical=20
Educational software focused on anatomy, = health-care=20 provision, or other medical practices.

Buyer Products:

  • The PDR Electronic Library on CD-ROM
=  
3D""=20 = Industry-Specific = =20
3D""=20 = Finance = =20
3D""=20 = Commercial Bank/Credit Union=20
Software designed specifically for = consumer/commercial=20 banks and credit unions.

Buyer Products:

  • Thomson ePIB=20
  • Elite Information Group WebView=20
  • Elite Information Group Enterprise
=  
3D""=20 = Investment Management/Brokerage=20
Software designed specifically for = investment-related=20 financial firms.

Buyer Products:

  • Datastream=20
  • First Call=20
  • IRA Analyst=20
  • iTarget=20
  • InvestmentView=20
  • ShareWatch Web=20
  • BondWatch=20
  • QUANTEC=20
  • Portia=20
  • Portfolio Analytics=20
  • Vestek Series=20
  • Master Tracker=20
  • Thomson ONE Banker=20
  • AutEx Series

Target Products:

  • Lipper, Inc. - Horizon=20
  • Reuters Kondor+=20
  • Reuters Wealth Manager=20
  • Reuters Portfolio Management System=20
  • Lipper, Inc. - Lipper Analytical New Application (LANA)=20
= =20
3D""=20 = Trading Software=20
Software designed to facilitate securities = trading in=20 capital markets.

Buyer Products:

  • Oneva Trade EQ=20
  • Quant Trading, Inc. Sector=20
  • Quant Trading, Inc. STARS=20
  • AutEx Series=20
  • Quant Trading, Inc. SMH

Target Products:

  • Reuters Xtra=20
  • Reuters Order Management=20
  • Reuters Trader=20
  • Equis MetaStock
= =20
3D""=20 = Healthcare/Pharma =  
3D""=20 = Business Management/Information Systems =  
3D""=20 = Operations Support =  
3D""=20 = Customer Relationship Management =  
3D""=20 = Patient-Provider Communications=20
Software designed to facilitate communications = between=20 multiple healthcare providers and their patients for the purpose = of=20 providing education and improving patient well-being.

Buyer Products:

  • MICROMEDEX CareNotes System
=  
3D""=20 = Enterprise Management =  
3D""=20 = Compliance Management=20
Software that helps healthcare providers = maintain=20 compliance with federal regulations, such as those imposed by = Medicare=20 regarding the validation of procedures.

Buyer Products:

  • IHI Liquent, Inc. InSight Manager Suite=20
  • IHI Liquent, Inc. CoreDossier=20
  • IHI Liquent, Inc. EZsubs Compliance=20
  • Solucient Insight Suite=20
  • IHI Liquent, Inc. DocXamine=20
  • IHI Liquent, Inc. RenderPerfect
=  
3D""=20 = Data Warehousing/Analysis/Query=20
Software that sorts, analyzes, and presents data = to help=20 healthcare providers improve their operational efficiency and = increase=20 profitability. Includes Data warehousing functionality.

Buyer Products:

  • MICROMEDEX - Medical Logic Modules
=  
3D""=20 = Financial/Asset Management =  
3D""=20 = Asset Management=20
Operations software that helps healthcare = providers track,=20 manage, and schedule the use of their assets, such as equipment, = staff and=20 facilities.

Buyer Products:

  • Solucient Insight Suite
=  
3D""=20 = Network Communications =  
3D""=20 = Integrated Delivery Network (IDN)=20
Software that helps manage the information needs = of an=20 integrated delivery network (IDN), including information sharing,=20 credential management, and relationship management.

Buyer Products:

  • MEDSTAT Advantage Suite=20
  • MEDSTAT Market Expert
=  
3D""=20 = Practice/Clinic Management =  
3D""=20 = General=20
Software that helps manage the information of a = specific=20 care unit, such as ambulatory, behavioral, surgery, cardiology, or = obstetrics.

Buyer Products:

  • MICROMEDEX DrugDex System=20
  • MICROMEDEX DISEASEDEX General Medicine=20
  • MICROMEDEX DISEASEDEX Emergency Medecine=20
  • Solucient Insight Suite
=  
3D""=20 = Hospital=20
Healthcare information systems designed to = handle the=20 needs of large hospitals.

Buyer Products:

  • MEDSTAT Ascent=20
  • Solucient Insight Suite
=  
3D""=20 = Managed Care=20
Information systems designed to manage the = information=20 needs of managed care organizations (MCOs) and other managed care=20 environments.

Buyer Products:

  • MEDSTAT Ascent
=  
3D""=20 = Pharmacy=20
Software designed to manage the information = needs of=20 pharmacies or pharmacists within other healthcare = organizations.

Buyer Products:

  • MICROMEDEX AltMedDex System=20
  • MICROMEDEX AltCareDex System=20
  • MICROMEDEX DrugKnowledge System=20
  • MICROMEDEX AltMed-REAX=20
  • MICROMEDEX AltMedDex Protocols=20
  • MIRCOMEDEX Pharmaceutical MSDS
=  
3D""=20 = Physician=20
Software that helps manage the information needs = of=20 individual or group physician's offices.

Buyer Products:

  • MICROMEDEX AltCareDex System=20
  • MICROMEDEX AltMedDex Protocols=20
  • MICROMEDEX mobileMICROMEDEX=20
  • MICROMEDEX AltMedDex System=20
  • MICROMEDEX Healthcare Series=20
  • MICROMEDEX IDENTIDEX System=20
  • MICROMEDEX IV INDEX System=20
  • MICROMEDEX AltMed-REAX=20
  • MICROMEDEX POISINDEX System=20
  • MICROMEDEX DRUG-REAX System
=  
3D""=20 = Legal =  
3D""=20 = Court Management=20
Software specifically for the management of = court=20 documents and information, including scheduling and fine=20 collections.

Buyer Products:

  • LiveNote
=  
3D""=20 = Practice Management=20
Software specifically for the management of a = law=20 practice.

Buyer Products:

  • Elite Information Group LawManager=20
  • Elite Information Group Enterprise=20
  • Elite Information Group WebView=20
  • Elite Information Group Records Management=20
  • Elite Information Group Document Studio=20
  • Elite Information Group Case Manager=20
  • Elite Information Group ProLaw=20
  • Elite Information Group Project and Resource Manager=20
  • Elite Information Group Conflicts Manager=20
  • ASIC Digest
=  
3D""=20 = Technology Services =  
3D""=20 = Information Technology (IT) =  
3D""=20 = Industry-Specific IT Services =  
3D""=20 = Financial Services=20
IT solutions tailored and marketed for the = financial=20 services industry.

Buyer Products:

  • Thomson IRChannel=20
  • Thomson/CCBN Webcasting=20
  • Thomson/CCBN IR Web Hosting=20
  • Thomson StreetEvents
=  
3D""=20 = Healthcare=20
IT solutions tailored and marketed for the = healthcare=20 industry.

Buyer Products:

  • Thomson Healthcare Solutions
=  
3D""=20 = Information Technology (IT) Consulting =  
3D""=20 = Enterprise Solutions =  
3D""=20 = Enterprise Resource Planning (ERP)=20
Design/Implementation of application-based = solutions that=20 facilitate the flow of information between all functions within a = company=20 such as manufacturing, logistics, enterprise content/document = management,=20 finance, and human resources.

Buyer Products:

  • BETA
=  
3D""=20 = Services =  
3D""=20 = Consumer Services =  
3D""=20 = Educational Services =  
3D""=20 = Educational Support Services=20
Companies which provide test preparation and = tutoring=20 services, as well as support services provided to colleges, such = as=20 consulting services and curriculum design and management.

Buyer Products:

  • Thomson Prometric
=  
3D""=20 = Post-Secondary =  
3D""=20 = Colleges=20
Colleges offering associate, bachelor, and = doctorate=20 programs. Online colleges are also included at this level.

Buyer Products:

  • Thomson Learning
=  
3D""=20 = Primary/Secondary =  
3D""=20 = Secondary=20
Secondary education services for students from = grades 7=20 through 12.

Buyer Products:

  • Thomson Learning
=  

3D""=20 - = Sector=20 Pure-Plays. Denotes that the company is focused in the selected sector = and=20 generates nearly all earnings in the sector/product area specified.

3D""=20 - = Sector=20 Participation. Denotes that the company develops products in this line = of=20 business.

Relationship = Details

Key = Competitors

  Name Dir Rel. Revenue % Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value =
Overlap
  3D""=20 = The=20 McGraw-Hill Companies, Inc. 3D""=20 = n/a 23,224.343 24.40 22.26 3.62 3.34 n/a
3D""=20 = Moody's=20 Corporation 3D""=20 = n/a 18,327.939 23.40 25.62 8.41 7.78 n/a
3D""=20 = Reed=20 Elsevier plc (ADR) 3D""=20 = n/a 16,608.442 25.10 17.54 2.91 n/a 7.99
3D""=20 = Reed=20 Elsevier NV (ADR) 3D""=20 = n/a 15,192.665 24.68 n/a 2.85 n/a 7.71
3D""=20 = Dow Jones=20 & Company, Inc. 3D""=20 = n/a 4,673.727 13.44 37.43 2.51 2.21 n/a
3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
3D""=20=20 Interactive Data Corp. 3D""=20 = n/a 2,794.430 28.18 27.48 4.43 4.22 11.98
3D""=20=20 Morningstar, Inc. 3D""=20 = n/a 2,192.798 42.36 34.31 6.96 5.42 19.95
3D""=20 = TNS, Inc.=20 3D""=20 = n/a 301.177 n/a 15.68 1.05 0.96 n/a
3D""=20 = EDGAR=20 Online, Inc. 3D""=20 = n/a 77.329 n/a -17.00 4.76 4.00 33.67
3D""=20 = Track Data=20 Corporation 3D""=20 = n/a 28.114 18.15 n/a 0.67 n/a 1.37
3D""=20 = HyperFeed=20 Technologies, Inc. 3D""=20 = n/a 0.153 n/a n/a 0.04 n/a n/a
3D""=20 = Bloomberg=20 L.P. 3D""=20 = n/a n/a n/a n/a n/a n/a n/a
3D""=20 = SunGard=20 Data Systems Inc. 3D""=20 = n/a n/a n/a n/a n/a n/a n/a
Buyer
  3D""=20 = France=20 Telecom (ADR) 3D""=20 = n/a 77,912.760 12.16 11.38 1.11 1.10 n/a
3D""=20=20 UnitedHealth Group Inc. 3D""=20 = n/a 70,798.115 16.88 15.46 0.97 0.92 3.36
Target
  3D""=20 = Citigroup=20 Inc. 3D""=20 = n/a 267,550.786 12.83 11.91 2.61 2.72 3.91
3D""=20=20 International Business Machines Corp. 3D""=20 = n/a 152,877.793 15.88 15.21 1.65 1.59 12.18
3D""=20 = Yahoo!=20 Inc. 3D""=20 = n/a 41,773.060 56.92 54.19 6.40 7.08 7.67
3D""=20 = The=20 Thomson Corporation (USA) 3D""=20 = n/a 27,807.113 22.55 26.03 4.09 3.59 n/a
3D""=20 = The=20 McGraw-Hill Companies, Inc. 3D""=20 = n/a 23,224.343 24.40 22.26 3.62 3.34 n/a
3D""=20 = Moody's=20 Corporation 3D""=20 = n/a 18,327.939 23.40 25.62 8.41 7.78 n/a
3D""=20 = Chicago=20 Mercantile Exchange Holdings 3D""=20 = n/a 17,957.712 40.27 35.49 15.34 13.08 11.02
3D""=20 = Reed=20 Elsevier plc (ADR) 3D""=20 = n/a 16,608.442 25.10 17.54 2.91 n/a 7.99
3D""=20 = Reed=20 Elsevier NV (ADR) 3D""=20 = n/a 15,192.665 24.68 n/a 2.85 n/a 7.71

3D""=20 - = Defined by=20 the Company 3D""=20 - = Defined by=20 Others

Dependent=20 Suppliers

  Name Dir Rel. Revenue % Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value =
Buyer
  3D""=20 = Onstream=20 Media Corp 3D""=20 = 4.00% 62.827 n/a n/a 7.19 n/a 15.39
3D""=20 = Broadcom=20 Corporation 3D""=20 = n/a 17,928.739 55.62 68.60 4.89 4.61 6.68
3D""=20 = Advanced=20 Micro Devices, Inc. 3D""=20 = n/a 7,437.871 n/a -5.88 1.34 1.27 8.43
3D""=20 = Silicon=20 Laboratories 3D""=20 = n/a 1,786.477 10.17 73.89 4.21 4.96 2.77
3D""=20 = Manhattan=20 Associates, Inc. 3D""=20 = n/a 794.882 35.42 25.32 2.61 2.45 5.74
3D""=20 = Secure=20 Computing Corporation 3D""=20 = n/a 536.607 n/a 161.00 3.04 2.09 n/a
3D""=20 = Taleo=20 Corporation 3D""=20 = n/a 405.366 n/a 100.31 4.18 3.36 5.65
3D""=20=20 SupportSoft, Inc. 3D""=20 = n/a 236.529 n/a -13.31 5.25 4.36 1.98
3D""=20 = QSound=20 Labs, Inc. (USA) 3D""=20 = n/a 48.011 n/a n/a 24.14 n/a 17.58
3D""=20 = VCampus=20 Corporation 3D""=20 = n/a 1.639 n/a n/a 0.22 n/a n/a
Target
  3D""=20 = Tibco=20 Software Inc. 3D""=20 = 5.00% 1,888.942 24.33 27.09 3.58 3.23 3.12
3D""=20 = BT Group=20 plc (ADR) 3D""=20 = n/a 52,343.063 10.08 14.45 1.30 1.33 18.89
3D""=20 = MasterCard=20 Incorporated 3D""=20 = n/a 18,190.909 131.48 31.87 5.19 4.81 8.67
3D""=20 = SAVVIS,=20 Inc. 3D""=20 = n/a 2,643.053 n/a -126.64 3.35 3.15 n/a
3D""=20 = Golden=20 Telecom, Inc. 3D""=20 = n/a 2,246.652 26.28 20.05 2.63 1.99 4.32
3D""=20 = Avid=20 Technology, Inc. 3D""=20 = n/a 1,401.986 n/a 34.93 1.54 1.45 4.23
3D""=20=20 Macrovision Corporation 3D""=20 = n/a 1,258.128 38.08 24.70 5.08 4.39 4.13
3D""=20 = Asia=20 Satellite Telecommunications (ADR) 3D""=20 = n/a 821.509 14.14 n/a 6.90 n/a 1.45
3D""=20=20 Interwoven, Inc. 3D""=20 = n/a 686.884 213.06 28.63 3.54 3.00 6.52
3D""=20 = iPass Inc.=20 3D""=20 = n/a 333.102 n/a -105.60 1.82 1.75 2.55
3D""=20 = ProQuest=20 Company 3D""=20 = n/a 290.597 5.47 -32.00 0.53 n/a n/a
3D""=20 = Globecomm=20 Systems, Inc. 3D""=20 = n/a 220.010 40.26 28.17 1.71 1.50 3.31
3D""=20 = IONA=20 Technologies Plc (ADR) 3D""=20 = n/a 194.017 663.97 n/a 2.54 2.34 5.41
3D""=20 = EDGAR=20 Online, Inc. 3D""=20 = n/a 77.329 n/a -17.00 4.76 4.00 33.67

3D""=20 - = Defined by=20 the Company 3D""=20 - = Defined by=20 Others

Key = Customers

  Name Dir Rel. Revenue % Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value =
Overlap
  3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
Buyer
  3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
3D""=20 = US=20 Dataworks, Inc. 3D""=20 = n/a 20.111 n/a n/a 2.94 n/a 36.04
Target
  3D""=20 = Citigroup=20 Inc. 3D""=20 = n/a 267,550.786 12.83 11.91 2.61 2.72 3.91
3D""=20 = JPMorgan=20 Chase & Co. 3D""=20 = n/a 179,799.867 11.13 11.98 2.88 2.58 3.11
3D""=20 = Barclays=20 PLC (ADR) 3D""=20 = n/a 95,603.515 10.46 10.91 2.19 2.09 3.83
3D""=20 = ABN AMRO=20 Holding N.V. (ADR) 3D""=20 = n/a 92,459.713 14.37 16.63 1.72 2.68 4.43
3D""=20 = Allianz SE=20 (ADR) 3D""=20 = n/a 90,827.375 10.36 10.17 0.68 0.64 2.12
3D""=20 = Yahoo!=20 Inc. 3D""=20 = n/a 41,773.060 56.92 54.19 6.40 7.08 7.67
3D""=20 = Lehman=20 Brothers Holdings Inc. 3D""=20 = n/a 41,171.403 10.29 10.25 0.82 2.08 2.50
3D""=20 = First Data=20 Corporation 3D""=20 = n/a 24,581.360 19.53 26.24 3.38 3.19 n/a
3D""=20 = MasterCard=20 Incorporated 3D""=20 = n/a 18,190.909 131.48 31.87 5.19 4.81 8.67
3D""=20 = Hutchison=20 Telecom Intl. Limited (ADR) 3D""=20 = n/a 9,817.903 381.33 111.21 2.30 n/a n/a
3D""=20 = Central=20 European Media Enterprises Ltd. 3D""=20 = n/a 3,891.272 190.54 33.87 6.45 5.64 n/a
3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
3D""=20 = Fortis=20 Incorporated 3D""=20 = n/a 3,069.714 23.86 n/a 2.39 n/a 4.83
3D""=20 = Siebert=20 Financial Corp. 3D""=20 = n/a 80.826 23.60 n/a 2.48 n/a 2.06
3D""=20 = Bank of=20 Communications Co., Ltd. 3D""=20 = n/a n/a n/a n/a n/a n/a n/a
3D""=20=20 Susquehanna International Group, LLP 3D""=20 = n/a n/a n/a n/a n/a n/a n/a
3D""=20 = People's=20 Bank of China 3D""=20 = n/a n/a n/a n/a n/a n/a n/a
3D""=20 = Government=20 - China 3D""=20 = n/a n/a n/a n/a n/a n/a n/a

3D""=20 - = Defined by=20 the Company 3D""=20 - = Defined by=20 Others

Key = Partners

  Name Dir Rel. Revenue % Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value =
Overlap
  3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
Buyer
  3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
3D""=20 = Blackboard=20 Inc. 3D""=20 = n/a 1,133.126 n/a 96.64 6.19 4.53 n/a
3D""=20 = Onstream=20 Media Corp 3D""=20 = n/a 62.827 n/a n/a 7.19 n/a 15.39
3D""=20 = US=20 Dataworks, Inc. 3D""=20 = n/a 20.111 n/a n/a 2.94 n/a 36.04
Target
  3D""=20 = BT Group=20 plc (ADR) 3D""=20 = n/a 52,343.063 10.08 14.45 1.30 1.33 18.89
3D""=20 = Yahoo!=20 Inc. 3D""=20 = n/a 41,773.060 56.92 54.19 6.40 7.08 7.67
3D""=20 = Accenture=20 Ltd. 3D""=20 = n/a 30,439.172 23.97 20.44 1.56 1.60 21.44
3D""=20 = Chicago=20 Mercantile Exchange Holdings 3D""=20 = n/a 17,957.712 40.27 35.49 15.34 13.08 11.02
3D""=20 = Hutchison=20 Telecom Intl. Limited (ADR) 3D""=20 = n/a 9,817.903 381.33 111.21 2.30 n/a n/a
3D""=20 = Central=20 European Media Enterprises Ltd. 3D""=20 = n/a 3,891.272 190.54 33.87 6.45 5.64 n/a
3D""=20 = Nasdaq=20 Stock Market Inc. 3D""=20 = n/a 3,714.282 29.20 25.76 2.24 3.52 17.03
3D""=20 = FactSet=20 Research Systems Inc. 3D""=20 = n/a 3,091.010 32.62 31.07 7.20 6.49 14.39
3D""=20 = SAVVIS,=20 Inc. 3D""=20 = n/a 2,643.053 n/a -126.64 3.35 3.15 n/a
3D""=20 = Novell,=20 Inc. 3D""=20 = n/a 2,457.833 314.75 n/a 2.57 2.49 3.77
3D""=20 = GFI Group=20 Inc. 3D""=20 = n/a 2,105.420 34.47 24.11 2.82 2.24 9.41
3D""=20 = Tibco=20 Software Inc. 3D""=20 = n/a 1,888.942 24.33 27.09 3.58 3.23 3.12
3D""=20 = Investment=20 Technology Group 3D""=20 = n/a 1,680.812 17.17 15.95 2.80 2.47 11.95
3D""=20=20 Macrovision Corporation 3D""=20 = n/a 1,258.128 38.08 24.70 5.08 4.39 4.13
3D""=20=20 NetRatings, Inc. 3D""=20 = n/a 751.080 265.58 n/a 9.19 n/a 4.06
3D""=20=20 TheStreet.com, Inc. 3D""=20 = n/a 292.779 22.75 20.55 5.75 4.91 7.81
3D""=20 = Siebert=20 Financial Corp. 3D""=20 = n/a 80.826 23.60 n/a 2.48 n/a 2.06
3D""=20 = Attunity=20 Ltd 3D""=20 = n/a 28.269 n/a n/a 2.12 n/a 16.06
3D""=20 = Semotus=20 Solutions, Inc. 3D""=20 = n/a 3.754 n/a n/a 2.00 n/a 26.62
3D""=20 = Cygnus=20 Solutions 3D""=20 = n/a n/a n/a n/a n/a n/a n/a

3D""=20 - = Defined by=20 the Company 3D""=20 - = Defined by=20 Others

Financials

Scenario 1:=20
Buyer's Share Price: 43.45; Target's Share Price: = 74.76;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 2:=20
Buyer's Share Price: 43.45; Target's Share Price: = 82.24;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 3:=20
Buyer's Share Price: 43.45; Target's Share Price: = 89.71;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;=20
Scenario 4:=20
Buyer's Share Price: 43.45; Target's Share Price: = 97.19;=20 Deal: 100.00%/0.00%/0.00%; Cost of Cash/Debt: = 5.00%/6.00%; Years=20 to Amortize Acquired Intangibles: 7;
  Buyer Target Scenario 1 Scenario 2 Scenario 3 Scenario 4
Income Statement
Operating = Items
Revenue 6,803.0 5,107.0 11,910.0 11,910.0 11,910.0 11,910.0
Other = Revenue = 0.0 0.0 0.0 0.0 0.0 0.0
Total Revenue 6,803.0 5,107.0 11,910.0 11,910.0 11,910.0 11,910.0
Cost of=20 Revenue = 4,836.0 4,679.1 9,515.1 9,515.1 9,515.1 9,515.1
SG&A=20 Expense3D"" 0.0 0.0 0.0 0.0 0.0 0.0
Depreciation=20 & Amortization3D""=20 = 692.0 0.0 692.0 692.0 692.0 692.0
Interest=20 Expense3D"" 0.0 0.0 0.0 0.0 0.0 0.0
Other = Operating=20 Expense = 0.0 -81.6 -81.6 -81.6 -81.6 -81.6
Total Expenses 5,528.0 4,597.5 10,125.5 10,125.5 10,125.5 10,125.5
Operating=20 Income3D""=20 = 1,275.0 509.5 1,784.5 1,784.5 1,784.5 1,784.5
Non Operating = Items
Interest=20 Expense (Inc.), Net Non-Oprtng3D"" -222.0 -37.8 -259.8 -259.8 -259.8 -259.8
Gain/Loss On=20 Sale Of Assets = 6.0 151.3 157.3 157.3 157.3 157.3
Other, = Net3D""=20 = -37.0 0.0 -37.0 -37.0 -37.0 -37.0
Income Before Taxes = 1,022.0 622.9 1,644.9 1,644.9 1,644.9 1,644.9
Income Taxes 98.0 39.8 157.7 157.7 157.7 157.7
Income After Taxes = 924.0 583.1 1,487.2 1,487.2 1,487.2 1,487.2
U.S. GAAP Adjustment = 31.0 0.0 n/a n/a n/a n/a
Net Income - = Excl. Xord.=20 Items3D"" 955.0 583.1 1,518.2 1,518.2 1,518.2 1,518.2
Discontinued = Operations 283.0 23.9 n/a n/a n/a n/a
Net Income - = Incl. Xord.=20 Items3D"" 1,238.0 607.0 1,825.1 1,825.1 1,825.1 1,825.1
Preferred Dividends = -5.0 0.0 -5.0 -5.0 -5.0 -5.0
Income Avail. to = Common = 1,233.0 607.0 1,820.1 1,820.1 1,820.1 1,820.1
Share Items
Basic Avg. Shares=20 Outstanding3D"" 641.1 212.2 1,011.0 1,048.0 1,084.9 1,121.9
Basic EPS - = Excl. Xord.=20 Items3D"" 1.48 2.75 1.50 1.44 1.39 1.35
Basic EPS - = Incl. Xord.=20 Items3D"" 1.92 2.86 1.80 1.74 1.68 1.62
Full Dilution = Adjustment 0.0 0.0 n/a n/a n/a n/a
Fully Diluted Shares = Outstanding=20 643.8 215.0 1,013.7 1,050.7 1,087.7 1,124.6
F.D. = EPS - Excl.=20 Xord. Items = 1.48 2.71 1.49 1.44 1.39 1.35
F.D. = EPS - Incl.=20 Xord. Items = 1.92 2.82 1.80 1.73 1.67 1.62
Dividends Per Common = Share 0.90 1.31 n/a n/a n/a n/a
Balance Sheet
Assets
Cash and=20 Equivalents3D""=20 = 350.0 256.7 606.7 606.7 606.7 606.7
ST=20 Investments3D"" 0.0 418.0 418.0 418.0 418.0 418.0
Accounts=20 Receivable3D""=20 = 1,285.0 513.5 1,798.5 1,798.5 1,798.5 1,798.5
Inventory = 80.0 2.0 82.0 82.0 82.0 82.0
Prepayments and=20 Advances = 303.0 0.0 303.0 303.0 303.0 303.0
Other=20 Current Assets3D""=20 = 1,021.0 15.9 1,036.9 1,036.9 1,036.9 1,036.9
Current Assets3D""=20 = 3,039.0 1,206.1 4,245.1 4,245.1 4,245.1 4,245.1
Accum=20 D&A3D""=20 = 0.0 0.0 0.0 0.0 0.0 0.0
PPE, Net3D""=20 = 600.0 738.4 1,338.4 1,338.4 1,338.4 1,338.4
Goodwill & = Intangibles 10,797.0 1,112.5 27,639.2 29,246.4 30,853.6 32,460.8
Long Term Investments = 0.0 169.2 169.2 169.2 169.2 169.2
Other Assets 0.0 0.0 0.0 0.0 0.0 0.0
Other LT Assets3D""=20 = 5,602.0 595.1 6,197.1 6,197.1 6,197.1 6,197.1
Total Assets 20,038.0 3,821.3 23,859.3 23,859.3 23,859.3 23,859.3
Liabilities
Accounts Payable 0.0 977.2 977.2 977.2 977.2 977.2
Payable/Accrued 1,058.0 0.0 1,058.0 1,058.0 1,058.0 1,058.0
ST=20 Debt3D""=20 = 591.0 330.4 921.4 921.4 921.4 921.4
Curr Port=20 of LTD & Cap Lease Oblg = 661.0 0.0 661.0 661.0 661.0 661.0
Other (Current) = Liabilities 1,715.0 509.5 2,224.5 2,224.5 2,224.5 2,224.5
Current Liab.3D""=20 = 4,025.0 1,817.1 5,842.1 5,842.1 5,842.1 5,842.1
LT=20 Debt3D""=20 = 3,275.0 1,036.9 4,311.9 4,311.9 4,311.9 4,311.9
Total LT Debt3D""=20 = 3,275.0 1,036.9 4,311.9 4,311.9 4,311.9 4,311.9
Deferred Taxes 987.0 218.9 1,205.9 1,205.9 1,205.9 1,205.9
Other LT Liab.3D""=20 = 1,241.0 406.0 1,647.0 1,647.0 1,647.0 1,647.0
Total Liabilities3D""=20 = 9,528.0 3,479.0 13,007.0 13,007.0 13,007.0 13,007.0
Shareholders = Equity
Common Stock 0.0 706.5 706.5 706.5 706.5 706.5
Additional Paid in = Capital 0.0 280.6 280.6 280.6 280.6 280.6
Retained Earnings = 7,152.0 -527.4 6,624.6 6,624.6 6,624.6 6,624.6
Other Equity 3,358.0 -117.4 3,240.6 3,240.6 3,240.6 3,240.6
Total Equity3D""=20 = 10,510.0 342.3 10,852.3 10,852.3 10,852.3 10,852.3
Total Liab. & = Equity = 20,038.0 3,821.3 23,859.3 23,859.3 23,859.3 23,859.3
Shares = Outstanding = 640.0 237.0 1,009.9 1,046.9 1,083.9 1,120.8
Cash Flow
Operating Cash = Flow
CF Net Income 615.0 583.1 1,178.2 1,178.2 1,178.2 1,178.2
CF Depreciation 80.0 189.1 269.1 269.1 269.1 269.1
CF Amortization 77.0 91.6 168.6 168.6 168.6 168.6
CF Deferred Taxes = -160.0 0.0 -160.0 -160.0 -160.0 -160.0
Other Non-Cash Items = 349.0 -55.7 293.3 293.3 293.3 293.3
Change in Working = Capital 122.0 -294.6 -172.6 -172.6 -172.6 -172.6
Total Cash From = Operating=20 Activities 1,083.0 513.5 1,576.6 1,576.6 1,576.6 1,576.6
Investing Cash Flow = (not=20 calculated)
Capital Expenditures = -156.0 -453.8 n/a n/a n/a n/a
Other Investing Cash = Flows -733.0 11.9 n/a n/a n/a n/a
Total Cash From = Investing=20 Activities -889.0 -441.8 n/a n/a n/a n/a
Financing Cash Flow = (not=20 calculated)
Dividends Paid -293.0 -266.7 n/a n/a n/a n/a
Purchase Or Sale of = Stock -109.0 -985.2 n/a n/a n/a n/a
Purchase and = Retirement of Debt=20 38.0 537.4 n/a n/a n/a n/a
Other Financing Cash = Flow 27.0 -390.1 n/a n/a n/a n/a
Total Cash From = Financing=20 Activities -337.0 -1,104.6 n/a n/a n/a n/a
Exchange Rate Effects = 2.0 -25.9 n/a n/a n/a n/a
Net Change in Cash = -141.0 -1,058.8 n/a n/a n/a n/a
Cash Taxes Paid 321.0 67.7 n/a n/a n/a n/a
Cash Interest Paid = 244.0 121.4 n/a n/a n/a n/a

Accretion/Dilution Matrices

Cash as Percentage of the Total Consideration

  Consideration 0 - $16,071.99 Consideration 1 - $17,679.19 Consideration 2 - $19,447.11 Consideration 3 - $21,391.82
Cash % Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. %
0% 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
10% 1.47 -0.00 -0.00% 1.42 -0.06 -0.04% 1.36 -0.11 -0.08% 1.30 -0.17 -0.12%
20% 1.46 -0.02 -0.01% 1.40 -0.08 -0.05% 1.33 -0.14 -0.10% 1.27 -0.20 -0.14%
30% 1.43 -0.04 -0.03% 1.37 -0.10 -0.07% 1.31 -0.17 -0.12% 1.24 -0.24 -0.16%
40% 1.41 -0.06 -0.04% 1.34 -0.13 -0.09% 1.27 -0.20 -0.14% 1.20 -0.28 -0.19%
50% 1.39 -0.09 -0.06% 1.31 -0.16 -0.11% 1.24 -0.24 -0.16% 1.16 -0.32 -0.22%

Proforma Effect of Operating Synergies

  Consideration 0 - $16,071.99 Consideration 1 - $17,679.19 Consideration 2 - $19,447.11 Consideration 3 - $21,391.82
Synergies $ Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. % Proforma = EPS Acc./Dil. Acc./Dil. %
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%
$0.0 1.49 0.02 0.01% 1.44 -0.04 -0.02% 1.39 -0.09 -0.06% 1.33 -0.14 -0.10%

Quotes are delayed 20 minutes. Prices are in USD. = Index=20 Values =3D 100.00 on 01/01/94.  MRQ =3D most recent quarter, TTM = =3D trailing=20 twelve months.  Pricing Information is provided by HyperFeed = Technologies,=20 Inc.  Fundamental data is provided by Reuters=A9 2004.  = Copying and=20 redistribution prohibited.  SEC Filings are provided by EDGAR = Online. =20 Insider Trading and Institutional Holdings information is provided by = Vickers=20 Stock Research.  Estimates are provided by Zacks Investment = Research. =20 News is provided by NewsWare.  Dividend data provided by = Mergent. =20 Earnings announcement dates provided by Wall Street Horizon, Inc.  = Use of=20 this site constitutes acceptance of the Revere Data, LLC.  Revere=20 Subscription Agreement.  Copyright =A9 2007 Revere Data, LLC. All = rights=20 reserved.

------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/www/r-logo.gif R0lGODlhtwAsAOZ/AMLN5au62jY1NPL0+RUUFABTmTJsrOrt9lV8tY2s1KSz1tzi8CdkpXd0cyko J3mYyGSEu+Lm8qako9za2pWr1ImiznyUxHWQwoKdy8zKyrWzs5SRkrvG4fj5+/Pz88rW6Obq9MvS 573L4013spGkzezq6u7w96O73LPB3pqt062qqmyIvefm5p2amrTD4J612cfR5oWCgtXd7Ymeygld oEZyr4KXxWuLwABank5LSvv7+2OAtlRRUbKvr+Lg4AoKCsTS6KO12J6w1Tw6Oq++3m1pacXDw4qH h83Y63Jubhtho/X2+o2KioF+fv39/ri2tkVDQlxZWXGNwNHa7GeJv6i22JmWltbU1FhVVWlmZtTa 69DX6tDOzmFfXpSx12ZiYtTb63iWyGdkZFpYV0JAPx8eHtjW1srIx1FPTiMiIvv8/mNhYTtwry0s KzMxMXOWxpGOjn6ZyPDv79LQz9/e3uTi4oSayNvZ2Nje7pWo0Fd/uGdkY0tISJi02AAAAP///yH5 BAEAAH8ALAAAAAC3ACwAAAf/gH+Cg4SFhoeIiYqLjI2Oj5CRko06A5OXmJmam5ydfwdgnqKjpKWm hB0AJqesra6vhiAwsLS1tptgILe7vL2FlmofHb7Exa8ASJ8LxszNogAJH394S87W15IHJwlIOhHY 4OGKSyLcJpa+6BLr7O3sPuLhSF5Iq7whKYI+fvz9/v4EyMSIdw3ECyTDbC1AoGDQhn8QIZaRQJAY ABToBrhIRisCBAYACI2JSNLfhoq9XDzAQMQekCmvBtgZceEbIQElcxJAyUvlgwdxWv6JcMCVlkQR BSgVQKDkSZ62IgSo8PNnkAMR0Jk6UEWXIQkQBRR64iCiGKi8IsAIguGnkJCk/yKkgKAn1CExEMcY ymAWrS8nMlykqCACJqcFKagYMCClKCKc/54W6kuogZjLmDNfHvgnRuYjh6xovvLHh+bTl59mQI25 hRxEllljHuhZjIosJcRwYbQEiRAiyy4NIAJhBIQLJFwsavoPXqF9ECX/qZOzHw9BUPyJLUSHOT83 gsBW95NEUIPqZZoYoj7++p8fPs5D+fH6DwAbeRQQCbHF3p8OMHQggwiSLGGHEjg05sgTEt0FEQHO CWLFeH48hVc/ZRiyxz8ZmEdhD4JEQeEXhUw43kl3tPFHFFHksN0fMOwg44wyrmCDDSSIoEAKJ8ig lSIRXMAADQzMUIUCcC1y3v8/ORhy4T96iUShBoIc8U8hRvzgTxSDZFfdD4O0QSEBLEg5HpUZWNFZ CUa0MEgINMY5YwAW7CBFBRbMwAEHLkwBQB4YzKBAnXLKOIN/iuQQVmY5eOePAxEKUlY/Q7A2iAr/ 7DYIH/6kUccgjvKBGmd0/LNGDJY56gdFg0zKT6WoMQKnjBfciKMCVXAQAhgADBNBH0BwUIEeVIRB BQYLBDBCATjQAEEACpBgQ0OOlEEhRJAa8o8Ki7DwD6t/9PAPaIIw6E+HiTzUzw8eOPQtIe9OMoBX ioABQx43IJDAGwYgIIQMQvx0wQgMKFHFJXxd688YkQqiwT86MBLvH2L28+L/H0l0ushIFhPSwj9U OpwpKVsIcQEENbigmAF6eJEACAfYwQAOI1T1AAVE4OFEJOpeS0AO6BqyZE5NEuIoE4J87M8ThGAx XhaDQMZPF4PQUTE/GQ4ydElFQ5IsCVSwsdjYN7gQRwA6gNCHF8sW4HYNRMRRlRA/NsLxtVkjQsZ4 nEXtz1ksWNtPlK2OB66jAlw2huD9qDfI3tX1vQgMJo8w9uWLQSAEDB84EQIEODyQAALMWiCICURU oJwkrvaTg+IRSV6IltWdUQgP/ly3NZmE3DEeuyJTuMbs49neiB6YX15DBTaZIEIcbjP7xr4ydBLR TRI1LIi46BlShHbd+eP4/yBwjPdixui5SQj3OeXNCATJsxFHCISkwMAFIjAQPQPbeBFcJuLRDiEC +LdDfK8fDnCE0viRhrv5ATy388cQFjGE7hmCCf4AUyZucLkbCME/B5iB/pgVgCDgoAAriMAStpEA IGjiSYMrhNT6ASFD4I5SjnhYBv0BIhn6ozyKoB0/Xqcof6iPEDd8lSZm0K8K/O8PC7DBCaNXAASI wAIcGEQHtkGgTMyQH9L5Q8KgZIjWAZE3JXEPKoS4KkWY4R8gKoGj0lCfwvXjjJcAwCwIAYYdUPGP RBCBYwShhideQlV+0F4ROUSIN/LwEYwDyB0MgSl/TEARGFzXIGIwrkbCUf8UKKjBH6lYAzw4DwDV 8IS5/OG+QYzRH137g5XGMz7sQYRchThgdViFBgkSIpK8qxKFaumIPIhylG7DQR4GAYbCiGJrQ0TE Iv0Brl6OxwiHqOA/EphNCpVAEGn4ISE46Y8iDOILFMKmI5yQByUgM3oQoNd/ACBIT0DOH7JzZVIG 4Ybx7OQQItoWIthIEghe4ZOEuJofaviHL0bkn494p9uUkEVDEEUUkeRH0AwxzX5QRAcEjQgUEIG+ fvABEXOgENX+QEA/GIKc1vkDSMczUkgYAJk4MJ1fdkoL0v1xBEniqVBZYQEq4oAEQ01qKwIQPQQM UqlQHcUWCsCAikb1qqMMsMFTscrVrnrVF4EAADs= ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/1Level.gif R0lGODlhEAAQAJECAAAAMwAAAAAAAAAAACH5BAEAAAIALAAAAAAQABAAAAIclI+pyxL/moFRumqh nVjq/WVdE3rjQgViubVNAQA7 ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/focusS.gif R0lGODlhDQANAMQTADU6ZO7u8nR4lDc8ZqepvNbX37a4x87P2sXG0q+xwTI3YsDBzru8y9HS24OG oOLi6efn7KqsvjA1YP///wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAEA ABMALAAAAAANAA0AAAUo4CSOZGmeKBoUQZoMEhCdECDdymMyd2+Yjd7tcHL0BCkEYZFqOp+iEAA7 ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/5Level.gif R0lGODlhEAAQAKIAAMDAwDA1YDE2YTI3YX2Am1FVdAAAAAAAACH5BAEAAAAALAAAAAAQABAAQAMl CLrcLSHK6BYZkVRGpN5g1U2ZSJZhqq5gQRbbKVUyVbkTzO5OAgA7 ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/focusF.gif R0lGODlhDQANAJEAAAAAAP///wBmAP///yH5BAEAAAMALAAAAAANAA0AAAIXnI+pO+IvFHwyMuMu nmvalGnhNWqmVgAAOw== ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/focusP.gif R0lGODlhDQANAKIAAAAAAP///5kAAL5dXciVlf///wAAAAAAACH5BAEAAAUALAAAAAANAA0AAAMc WLrc/kVIOd6ctUlFthacx1yUQ2YftIgQq75wAgA7 ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/info-black.gif R0lGODlhCgALAJEAAAAAAP///////wAAACH5BAEAAAIALAAAAAAKAAsAAAIUhI8gy2v8nJJwNipO 3TjbiHRXQhYAOw== ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/2Level.gif R0lGODlhEAAQAJEAAMDAwP/MAIgAAAAAACH5BAEAAAAALAAAAAAQABAAQAInhI95wS0PEYStocrm kxoHPnkXpgnKiaZKKR4sBlLwQmpjVd6OrZ4FADs= ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/3Level.gif R0lGODlhEAAQAJEAAMDAwIgAAJkzMwAAACH5BAEAAAAALAAAAAAQABAAQAIdhI95we2sjItp0ktf yzrgD2LQp3GdV52oUpJrGBUAOw== ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/hierarchy/4Level.gif R0lGODlhEAAQAJEAAMDAwP/MAMzMzGZmZiH5BAEAAAAALAAAAAAQABAAQAIohI+pMuEjVGJRAuby q7bPBnWYFnrm2Q0oAJ7N472ZKsmkMuT6Tq9GAQA7 ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/entities/co.gif R0lGODlhCwAMAJEAAP///6CgoP///wAAACH5BAEAAAIALAAAAAALAAwAAAIYVI5oyQwPGoTpIXtj O3j3zk1aRW3NsgkFADs= ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/assoc/direct.gif R0lGODlhCwAMAMQAAGaZZmuda2qbam2ebXSjdHOhc3akdnileJq8mpy9nKHBoaC/oKXDpafEp7PM s87fztfl19nm2enx6ebu5uvy6+jv6O3z7fT49P///////wAAAAAAAAAAAAAAAAAAAAAAACH5BAEA ABkALAAAAAALAAwAAAU/YCaO5GgxB2Ao0hgNQBwHT3YRsYPJQdXIAMwuljAAg8OBAClsxoxAYWzA iA4BiFvuKphkIDAgbURh4AqLiigEADs= ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://research.reveredata.com/rp/images/assoc/reverse.gif R0lGODlhCwAMALMAAPXp8adIialMjKtRj6xTkK9ZlLBblbFel8qRuMuTusyWu9OkxOfN3/Tn8P// /////yH5BAEAAA8ALAAAAAALAAwAAAQ+8MlJJ0gnHAQmG0EYDswDEKKzhASgpI4YKEboxLIhBHd/ B4IaDycyJGCyRANkWwUGjcdH9ixJGohCoICIPiIAOw== ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://research.reveredata.com/rp/css/layout.reports.css BODY { PADDING-RIGHT: 0em; PADDING-LEFT: 0em; FONT-SIZE: 0.8em; BACKGROUND: = white; PADDING-BOTTOM: 0em; MARGIN: 0.5em 1em; COLOR: black; = PADDING-TOP: 0em; FONT-FAMILY: arial, sans-serif } @media Print =20 { BODY { MARGIN: 0em } THEAD { DISPLAY: table-header-group } TBODY { =09 } } HR { BORDER-TOP-STYLE: none; BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: = none; HEIGHT: 0.05em; BACKGROUND-COLOR: gray; BORDER-BOTTOM-STYLE: none } H1 { FONT-SIZE: 1.75em } H2 { PADDING-RIGHT: 0.2em; PADDING-LEFT: 0.2em; FONT-SIZE: 1.3em; = BACKGROUND: #e0e0e0; PADDING-BOTTOM: 0.1em; PADDING-TOP: 0.1em; = BORDER-BOTTOM: gray 0.2em solid } H3 { FONT-SIZE: 1.16em; BACKGROUND: #e0e0e0; MARGIN: 1em 0em 0.5em; = BORDER-BOTTOM: gray 0.2em solid } H4 { FONT-SIZE: 0.94em; MARGIN: 0.5em 0em 0.2em } H5 { FONT-SIZE: 0.8em; MARGIN: 0.5em 0em 0.2em } DIV.enclose-floats:unknown { CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: = "." } HTML .enclose-floats { HEIGHT: 1% } #header { =09 } #header H1 { MARGIN-TOP: 0.2em; FONT-SIZE: 1.75em; MARGIN-BOTTOM: 0em; = PADDING-BOTTOM: 0.2em; COLOR: black; PADDING-TOP: 0.2em; TEXT-ALIGN: = center } #header H2 { MARGIN-TOP: 0em; FONT-SIZE: 1.3em; BACKGROUND: none transparent scroll = repeat 0% 0%; MARGIN-BOTTOM: 0em; COLOR: #00356e; TEXT-ALIGN: center; = BORDER-BOTTOM-STYLE: none } #headerLogo { FLOAT: left; WIDTH: 184px } #headerTitle { CLEAR: both } #headerInfo { FLOAT: right; WIDTH: 15em } #headerInfo P { MARGIN: 0em; TEXT-ALIGN: right } #headerInfo SPAN.phone { =09 } #headerInfo SPAN.date { =09 } DIV#content { CLEAR: both } DIV#footer { CLEAR: both; PADDING-RIGHT: 0em; PADDING-LEFT: 0em; PADDING-BOTTOM: = 1em; PADDING-TOP: 1em } #footer P.disclaimer { TEXT-ALIGN: justify } .section { CLEAR: both } H2.section { MARGIN-BOTTOM: 0.5em } H3.section { MARGIN-BOTTOM: 0.5em } .pbr { PAGE-BREAK-BEFORE: always } P.disclaimer { FONT-SIZE: 0.8em } DIV.notes { FONT-SIZE: 0.8em } DIV.notes P { MARGIN-TOP: 0em; MARGIN-BOTTOM: 0em } ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://research.reveredata.com/rp/css/grid.reports.css .comment { FONT-SIZE: 7pt } .scroll-info { FONT-WEIGHT: bold } DIV.scroll-info { MARGIN-TOP: 3pt; MARGIN-BOTTOM: 0pt } P.scroll-info { MARGIN-TOP: 3pt; MARGIN-BOTTOM: 0pt } DL.column { MARGIN-TOP: 3pt; FONT-SIZE: 8pt; MARGIN-BOTTOM: 0pt } DL.column DT { FONT-WEIGHT: bold } TABLE.grid-list { BORDER-RIGHT: #c0c0c0 0.05em solid; BORDER-TOP: #c0c0c0 0.05em solid; = BORDER-LEFT: #c0c0c0 0.05em solid; BORDER-BOTTOM: #c0c0c0 0.05em solid; = BORDER-COLLAPSE: separate } TABLE.grid-list TH { PADDING-RIGHT: 0.4em; BORDER-TOP: #eeeeee 1px solid; PADDING-LEFT: = 0.4em; FONT-SIZE: 0.9em; PADDING-BOTTOM: 0.1em; BORDER-LEFT: #eeeeee 1px = solid; COLOR: black; PADDING-TOP: 0.1em; HEIGHT: 1.5em; = BACKGROUND-COLOR: #e0e0e0 } TABLE.grid-list TH.last { BORDER-RIGHT: #eeeeee 1px solid } TABLE.grid-list TR.last TH { BORDER-BOTTOM: gray 0.2em solid } TABLE.grid-list TR.bundle TH.bundle { BORDER-BOTTOM: gray 0.2em solid } TABLE.grid-list TR.bundle TH { BORDER-BOTTOM-STYLE: none } TABLE.grid-list TD { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; PADDING-BOTTOM: 0em; = VERTICAL-ALIGN: middle; PADDING-TOP: 0em; BORDER-BOTTOM: #eeeeee 0.05em = solid; HEIGHT: 1.5em } TABLE.grid-list TR.odd TD { BACKGROUND: white } TABLE.grid-list TR.even TD { BACKGROUND: #eeeeee } TABLE.grid-list TD.neg { COLOR: red } TABLE.grid-list TD.pos { COLOR: green } TABLE.grid-list TD.rpos { PADDING-RIGHT: 0.2em; PADDING-LEFT: 0em; PADDING-BOTTOM: 0em; WIDTH: = 1.5em; PADDING-TOP: 0em; TEXT-ALIGN: right } TABLE.grid-list TH.rpos { PADDING-RIGHT: 0.2em; PADDING-LEFT: 0em; PADDING-BOTTOM: 0em; WIDTH: = 1.5em; PADDING-TOP: 0em; TEXT-ALIGN: right } TABLE.grid-list TR.aggr TD { FONT-WEIGHT: bold; BACKGROUND: #dddddd } TABLE.grid-list TD.sel { PADDING-RIGHT: 0em; PADDING-LEFT: 0em; PADDING-BOTTOM: 0em; = PADDING-TOP: 0em; TEXT-ALIGN: center } TABLE.grid-list TH.sel { PADDING-RIGHT: 0em; PADDING-LEFT: 0em; PADDING-BOTTOM: 0em; = PADDING-TOP: 0em; TEXT-ALIGN: center } TABLE.grid-list TR.group TD { FONT-WEIGHT: bold; BACKGROUND: #e6e6e6; HEIGHT: 1.5em } TABLE.grid-list TR TD.band { FONT-WEIGHT: bold; BACKGROUND: #f0f0f0; WIDTH: 1em; BORDER-BOTTOM: = #eeeeee 0.05em solid; TEXT-ALIGN: right } TABLE.doc-table { BORDER-RIGHT: #c0c0c0 0.05em solid; BORDER-TOP: #c0c0c0 0.05em solid; = BORDER-LEFT: #c0c0c0 0.05em solid; BORDER-BOTTOM: #c0c0c0 0.05em solid; = BORDER-COLLAPSE: separate; border-spacing: 0px } TABLE.doc-table TH { PADDING-RIGHT: 0.4em; BORDER-TOP: #eeeeee 0.05em solid; PADDING-LEFT: = 0.4em; FONT-WEIGHT: bold; FONT-SIZE: 0.9em; PADDING-BOTTOM: 0.1em; = VERTICAL-ALIGN: bottom; BORDER-LEFT: #eeeeee 0.05em solid; PADDING-TOP: = 0.1em; BORDER-BOTTOM: #eeeeee 0.05em solid; BACKGROUND-COLOR: #e0e0e0 } TABLE.doc-table THEAD TD { PADDING-RIGHT: 0.4em; BORDER-TOP: #eeeeee 0.05em solid; PADDING-LEFT: = 0.4em; FONT-WEIGHT: bold; FONT-SIZE: 0.9em; PADDING-BOTTOM: 0.1em; = VERTICAL-ALIGN: bottom; BORDER-LEFT: #eeeeee 0.05em solid; PADDING-TOP: = 0.1em; BORDER-BOTTOM: #eeeeee 0.05em solid; BACKGROUND-COLOR: #e0e0e0 } TABLE.doc-table TD { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; PADDING-BOTTOM: 0em; = PADDING-TOP: 0em; BORDER-BOTTOM: #e6e6e6 0.05em solid; WHITE-SPACE: = nowrap; HEIGHT: 1.5em } TABLE.doc-table TH.last { BORDER-RIGHT: #eeeeee 1px solid } TABLE.doc-table THEAD TD.last { BORDER-RIGHT: #eeeeee 1px solid } TABLE.doc-table THEAD TR.last TD { BORDER-BOTTOM: gray 0.2em solid } TABLE.doc-table THEAD TR.last TH { BORDER-BOTTOM: gray 0.2em solid } TABLE.doc-table TBODY.caption { BACKGROUND: #999999 } TABLE.doc-table CAPTION { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; FONT-WEIGHT: bold; = BACKGROUND: #999999; PADDING-BOTTOM: 0.1em; COLOR: white; PADDING-TOP: = 0.1em; TEXT-ALIGN: left } TABLE.doc-table TBODY.caption TH { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; FONT-WEIGHT: bold; = BACKGROUND: #999999; PADDING-BOTTOM: 0.1em; COLOR: white; PADDING-TOP: = 0.1em; TEXT-ALIGN: left } TABLE.doc-table THEAD.caption TH { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; FONT-WEIGHT: bold; = BACKGROUND: #999999; PADDING-BOTTOM: 0.1em; COLOR: white; PADDING-TOP: = 0.1em; TEXT-ALIGN: left } TABLE.doc-table TBODY.caption TD { BORDER-BOTTOM-STYLE: none } TABLE.doc-table COL.even { BACKGROUND: #f4f4f4 } TABLE.doc-table TD.even { BACKGROUND: #f4f4f4 } TABLE.doc-table COL.odd { =09 } TABLE.doc-table TD.gr-end { BORDER-RIGHT: #e6e6e6 0.2em solid } TABLE.doc-table TH.gr-end { BORDER-RIGHT: #d0d0d0 0.2em solid } TABLE.doc-table TR.period-info TD.gr-end { BORDER-RIGHT: #d0d0d0 0.2em solid } TABLE.doc-table TD.neg { COLOR: red } TABLE.doc-table TD.pos { COLOR: green } TABLE.doc-table TR.aggr TD { FONT-WEIGHT: bold; BORDER-BOTTOM: #eeeeee 0.2em solid } TABLE.doc-table TD.aggr { FONT-WEIGHT: bold; BORDER-BOTTOM: #eeeeee 0.2em solid } TABLE.doc-table TR.aggr .last TD { BORDER-BOTTOM-STYLE: none } TABLE.doc-table TD.aggr .last { BORDER-BOTTOM-STYLE: none } TABLE.doc-table TR.gr-1 TD { BORDER-TOP: white 0.05em solid; FONT-WEIGHT: bold; BORDER-BOTTOM: = silver 0.05em solid; BACKGROUND-COLOR: #eeeeee; TEXT-ALIGN: left } TABLE.doc-table TD.gr-1 { BORDER-TOP: white 0.05em solid; FONT-WEIGHT: bold; BORDER-BOTTOM: = silver 0.05em solid; BACKGROUND-COLOR: #eeeeee; TEXT-ALIGN: left } TABLE.doc-table TR.gr-2 TD { FONT-WEIGHT: bold; BACKGROUND: #f0f0f0 } TABLE.doc-table TD.gr-2 { FONT-WEIGHT: bold; BACKGROUND: #f0f0f0 } TABLE.doc-table TR.period-info TD { FONT-WEIGHT: bold; BACKGROUND: #dddddd } TABLE.doc-table TD.period-info { FONT-WEIGHT: bold; BACKGROUND: #dddddd } TABLE.fund { BORDER-RIGHT: #c0c0c0 0.05em solid; BORDER-TOP: #c0c0c0 0.05em solid; = BORDER-LEFT: #c0c0c0 0.05em solid; BORDER-BOTTOM: #c0c0c0 0.05em solid } TABLE.fund TH { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; PADDING-BOTTOM: 0.1em; = VERTICAL-ALIGN: top; PADDING-TOP: 0.1em; BORDER-BOTTOM: #e6e6e6 1px = solid; BACKGROUND-COLOR: #eeeeee } TABLE.fund TH DIV.edate { FONT-WEIGHT: normal } TABLE.fund TH.head { VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #e0e0e0; TEXT-ALIGN: left; = BORDER-RIGHT-WIDTH: 0px } TABLE.fund TH.row { FONT-WEIGHT: normal; TEXT-ALIGN: left } TABLE.fund TR.aggr TD { BORDER-TOP: #e6e6e6 0.2em solid; BORDER-BOTTOM-STYLE: none } TABLE.fund TR.aggr TH { BORDER-TOP: #e6e6e6 0.2em solid; BORDER-BOTTOM-STYLE: none } TABLE.fund TR.aggr TD { FONT-WEIGHT: normal } TABLE.fund TD { BORDER-RIGHT: #e6e6e6 0.05em solid } TABLE.fund TH { BORDER-RIGHT: #e6e6e6 0.05em solid } TABLE.fund TR TD DIV.e { FONT-WEIGHT: bold } TABLE.list IMG.a { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.list IMG.e { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.a { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.e { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.a { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.e { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.a { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.e { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } DIV.notes IMG.a { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } DIV.notes IMG.e { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 11px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 12px; BORDER-BOTTOM-STYLE: none } TABLE.list IMG.f { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 13px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.f { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 13px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.f { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 13px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.f { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 13px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } DIV.notes IMG.f { MARGIN-LEFT: 1px; VERTICAL-ALIGN: middle; WIDTH: 13px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 1px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.list IMG.l1 { MARGIN-LEFT: 2px; VERTICAL-ALIGN: middle; WIDTH: 16px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 9px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 16px; BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.l1 { MARGIN-LEFT: 2px; VERTICAL-ALIGN: middle; WIDTH: 16px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 9px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 16px; BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.l1 { MARGIN-LEFT: 2px; VERTICAL-ALIGN: middle; WIDTH: 16px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 9px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 16px; BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.l1 { MARGIN-LEFT: 2px; VERTICAL-ALIGN: middle; WIDTH: 16px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 9px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 16px; BORDER-BOTTOM-STYLE: none } TABLE.list IMG.h { VERTICAL-ALIGN: middle; WIDTH: 16px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 16px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.h { VERTICAL-ALIGN: middle; WIDTH: 16px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 16px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.h { VERTICAL-ALIGN: middle; WIDTH: 16px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 16px; = BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.h { VERTICAL-ALIGN: middle; WIDTH: 16px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 16px; = BORDER-BOTTOM-STYLE: none } TABLE.list IMG.p { MARGIN-LEFT: 4px; VERTICAL-ALIGN: middle; WIDTH: 19px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 4px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.p { MARGIN-LEFT: 4px; VERTICAL-ALIGN: middle; WIDTH: 19px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 4px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.p { MARGIN-LEFT: 4px; VERTICAL-ALIGN: middle; WIDTH: 19px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 4px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.p { MARGIN-LEFT: 4px; VERTICAL-ALIGN: middle; WIDTH: 19px; = BORDER-TOP-STYLE: none; MARGIN-RIGHT: 4px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; HEIGHT: 13px; BORDER-BOTTOM-STYLE: none } TABLE.list IMG.sort { VERTICAL-ALIGN: middle; WIDTH: 7px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 7px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.sort { VERTICAL-ALIGN: middle; WIDTH: 7px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 7px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.sort { VERTICAL-ALIGN: middle; WIDTH: 7px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 7px; = BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.sort { VERTICAL-ALIGN: middle; WIDTH: 7px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 7px; = BORDER-BOTTOM-STYLE: none } TABLE.list TH IMG.sort { MARGIN-LEFT: 0.2em } TABLE.grid-list THEAD IMG.sort { MARGIN-LEFT: 0.2em } TABLE.grid-table TH IMG.sort { MARGIN-LEFT: 0.2em } TABLE.doc-table THEAD IMG.sort { MARGIN-LEFT: 0.2em } TABLE.list IMG.i { VERTICAL-ALIGN: middle; WIDTH: 10px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 11px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-list IMG.i { VERTICAL-ALIGN: middle; WIDTH: 10px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 11px; = BORDER-BOTTOM-STYLE: none } TABLE.grid-table IMG.i { VERTICAL-ALIGN: middle; WIDTH: 10px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 11px; = BORDER-BOTTOM-STYLE: none } TABLE.doc-table IMG.i { VERTICAL-ALIGN: middle; WIDTH: 10px; BORDER-TOP-STYLE: none; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; HEIGHT: 11px; = BORDER-BOTTOM-STYLE: none } TABLE.list TH IMG.i { MARGIN-LEFT: 0.2em } TABLE.grid-list THEAD IMG.i { MARGIN-LEFT: 0.2em } TABLE.grid-table TH IMG.i { MARGIN-LEFT: 0.2em } TABLE.doc-table THEAD IMG.i { MARGIN-LEFT: 0.2em } TABLE.doc-table TBODY TD IMG.i { MARGIN-LEFT: 0.2em } TABLE.sector-list { =09 } TABLE.sector-list TD.focus { FONT-WEIGHT: bold; WIDTH: 5%; TEXT-ALIGN: center } TABLE.sector-list TD.number { WIDTH: 10%; TEXT-ALIGN: right } TABLE.sector-list TBODY TR.leaf TD SPAN.name { FONT-WEIGHT: bold } TABLE.sector-list TBODY TR.leaf TD DIV.desc { MARGIN-BOTTOM: 0.2em; MARGIN-LEFT: 20px } TABLE.sector-list TBODY TR TD DIV.tn { DISPLAY: none } TABLE.sector-list TBODY TR.leaf TD DIV.tn { PADDING-RIGHT: 0.5em; DISPLAY: block; PADDING-LEFT: 20px; = MARGIN-BOTTOM: 0.2em; PADDING-BOTTOM: 0.2em; MARGIN-LEFT: 20px; = PADDING-TOP: 0.2em } TABLE.sector-list TBODY TR.leaf TD DIV.tn H4 { FONT-WEIGHT: normal; MARGIN: 0.2em 0em } TABLE.sector-list TBODY TR.leaf TD DIV.tn H4 SPAN.name { FONT-WEIGHT: bold } TABLE.sector-list TBODY TR.leaf TD DIV.tn H4 SPAN.ticker { COLOR: navy } TABLE.sector-list TBODY TR.leaf TD UL.tn { MARGIN-TOP: 0.2em; MARGIN-BOTTOM: 0.2em } TABLE.sector-list TBODY TR.leaf TD UL.tn LI { =09 } BODY.print TABLE.grid-list TBODY TR.group TD.head { BORDER-TOP: white 1px solid; FONT-WEIGHT: bold; BACKGROUND: #eeeeee; = BORDER-BOTTOM: silver 1px solid; HEIGHT: 14.5pt } BODY.print TABLE.grid-list TBODY TR.group TD.band { BORDER-RIGHT: #eeeeee 1px solid; FONT-WEIGHT: bold; BACKGROUND: = #e0e0e0; VERTICAL-ALIGN: top; WIDTH: 9pt; PADDING-TOP: 0.2em; = TEXT-ALIGN: right } BODY.print TABLE.grid-list TBODY TR TD.band { FONT-WEIGHT: bold; BACKGROUND: #e0e0e0; WIDTH: 9pt; BORDER-BOTTOM: = #eeeeee 1px solid; TEXT-ALIGN: right } BODY.print TABLE.grid-list TBODY TR.last TD { BORDER-BOTTOM-STYLE: none } BODY.print TABLE.grid-list TBODY TR.last TD.band { BORDER-BOTTOM: white 1px solid } ------=_NextPart_000_0046_01C78E5E.17466D70 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://research.reveredata.com/rp/css/reports/mna.css H2 SPAN.buyer { BORDER-BOTTOM: #cadfed 0.25em solid } H2 SPAN.target { BORDER-BOTTOM: #edeaca 0.25em solid } H2 SPAN.label { FONT-WEIGHT: normal } SPAN.ticker { COLOR: navy } TABLE.grid-list COL.buyer { BACKGROUND: #f0f6fa } TABLE.doc-table COL.buyer { BACKGROUND: #f0f6fa } TABLE.grid-list COL.target { BACKGROUND: #faf9f0 } TABLE.doc-table COL.target { BACKGROUND: #faf9f0 } TABLE.grid-list COL.combined { BACKGROUND: #f3f6f3 } TABLE.doc-table COL.combined { BACKGROUND: #f3f6f3 } DIV.key-focus DIV H5 { MARGIN: 0.2em 0.5em } DIV.desc DIV H5 { MARGIN: 0.2em 0.5em } DIV.key-focus DIV.buyer { BACKGROUND: #f0f6fa; FLOAT: left; WIDTH: 49.5% } DIV.desc DIV.buyer { BACKGROUND: #f0f6fa; FLOAT: left; WIDTH: 49.5% } DIV.key-focus DIV.target { BACKGROUND: #faf9f0; FLOAT: right; WIDTH: 49.5% } DIV.desc DIV.target { BACKGROUND: #faf9f0; FLOAT: right; WIDTH: 49.5% } DIV.key-focus DIV.buyer P { MARGIN: 0.2em 1em } DIV.key-focus DIV.target P { MARGIN: 0.2em 1em } DIV.desc DIV.buyer P { MARGIN: 0.2em 1em } DIV.desc DIV.target P { MARGIN: 0.2em 1em } DIV.key-focus IMG.focus { VERTICAL-ALIGN: middle; WIDTH: 13px; HEIGHT: 13px } DIV.key-fin DIV.buyer { FLOAT: left; WIDTH: 49.5% } DIV.key-fin DIV.target { FLOAT: right; WIDTH: 49.5% } DIV.tech { BORDER-RIGHT: silver 0.05em solid; BORDER-TOP: silver 0.05em; = BORDER-LEFT: silver 0.05em solid; BORDER-BOTTOM: silver 0.05em solid } DIV.tech TABLE.doc-table { MARGIN-BOTTOM: 0.5em; BORDER-RIGHT-STYLE: none! important; = BORDER-LEFT-STYLE: none! important } DIV.tech DIV.buyer { MARGIN-BOTTOM: 0.5em; PADDING-TOP: 0.5em; TEXT-ALIGN: center } DIV.tech DIV.target { MARGIN-BOTTOM: 0.5em; PADDING-TOP: 0.5em; TEXT-ALIGN: center } DIV.tech DIV.buyer { FLOAT: left; WIDTH: 49.5% } DIV.tech DIV.target { FLOAT: right; BORDER-LEFT: silver 1px solid; WIDTH: 49.5% } DIV.tech H3 { MARGIN-TOP: 0em; MARGIN-BOTTOM: 0em; BORDER-BOTTOM-STYLE: none } DIV.fund DIV.buyer { FLOAT: left; WIDTH: 49.5% } DIV.fund DIV.target { FLOAT: right; WIDTH: 49.5% } DIV.fund DIV.buyer TABLE.fund { BACKGROUND: #f0f6fa; WIDTH: 100% } DIV.fund DIV.target TABLE.fund { BACKGROUND: #faf9f0; WIDTH: 100% } DIV.fund DIV H5 { MARGIN: 0.2em 0em } TABLE.sector-list { WIDTH: 100% } TABLE.sector-list TBODY TR.leaf TD DIV.buyer { BACKGROUND: #f0f6fa; MARGIN-BOTTOM: 0.2em } TABLE.sector-list TBODY TR.leaf TD DIV.target { BACKGROUND: #faf9f0; MARGIN-BOTTOM: 0.2em } TABLE.doc-table { WIDTH: 100% } TABLE.doc-table COL.label { WIDTH: 40%; TEXT-ALIGN: left } DIV.scenario { BORDER-RIGHT: silver 0.05em solid; BORDER-TOP: silver 0.05em solid; = FLOAT: right; BORDER-LEFT: silver 0.05em solid; WIDTH: 10em; = BORDER-BOTTOM: silver 0.05em solid } DIV.scenario H3 { MARGIN: 0.2em 0.5em } DIV.header { MARGIN-RIGHT: 11em; HEIGHT: 1% } DIV.summary { MARGIN-RIGHT: 11em; HEIGHT: 1% } TABLE.summary { BORDER-RIGHT: silver 0.05em solid; BORDER-TOP: silver 0.05em solid; = BORDER-LEFT: silver 0.05em solid; WIDTH: 100%; BORDER-BOTTOM: silver = 0.05em solid } TABLE.summary TBODY TH { PADDING-RIGHT: 0.4em; PADDING-LEFT: 0.4em; PADDING-BOTTOM: 0.1em; = PADDING-TOP: 0.1em; TEXT-ALIGN: left } TABLE.summary TBODY TR.buyer TH { BORDER-BOTTOM: #eeeeee 0.05em solid } TABLE.summary TBODY TR.target TH { =09 } TABLE.summary TBODY TD { PADDING-RIGHT: 1em; PADDING-LEFT: 0.4em; PADDING-BOTTOM: 0.1em; = PADDING-TOP: 0.1em } TABLE.summary TBODY TR.buyer TD { BACKGROUND: #f0f6fa; BORDER-BOTTOM: #eeeeee 0.05em solid } TABLE.summary TBODY TR.target TD { BACKGROUND: #faf9f0 } TABLE.summary TBODY TD.number { TEXT-ALIGN: right } UL.summary LI EM { FONT-STYLE: normal } UL.scenario { =09 } UL.scenario LI { MARGIN-LEFT: -1em } UL.scenario LI.first { =09 } TABLE.sidebside { WIDTH: 100% } TABLE.sidebside TD { VERTICAL-ALIGN: top } TABLE.sidebside TD.buyer { BACKGROUND: #f0f6fa } TABLE.sidebside TD.target { BACKGROUND: #faf9f0 } TABLE.sidebside H4 { MARGIN: 0.5em 0em 0em } TABLE.sidebside H5 { MARGIN: 0.2em 0.5em } TABLE.sidebside H5 SPAN.info { FONT-WEIGHT: normal } TABLE.sidebside H5 SPAN.info EM { FONT-WEIGHT: bold; FONT-STYLE: normal } TABLE.sidebside UL { MARGIN-TOP: 0em; MARGIN-BOTTOM: 0em } TABLE.sidebside UL LI { MARGIN-LEFT: -1em } TABLE.sidebside P.na { MARGIN: 2em 0em; TEXT-ALIGN: center } ------=_NextPart_000_0046_01C78E5E.17466D70--